( (TITLE (NP (NP (ADJP (JJ Conditional) (CC and) (JJ inducible)) (NN transgene) (NN expression)) (PP-LOC (IN in) (NP (NNS mice))) (PP (IN through) (NP (NP (DT the) (JJ combinatorial) (NN use)) (PP (IN of) (NP (NP (ADJP (NN Cre) (HYPH -) (VBN mediated)) (NN recombination)) (CC and) (NP (NN tetracycline) (NN induction)))))))) )
( (HEADING (NP (NN Abstract))) )
( (S (ADVP (RB Here)) (NP-SBJ (PRP we)) (VP (VBP describe) (NP (NP (DT a) (ADJP (JJ triple) (JJ transgenic)) (NN mouse) (NN system)) (, ,) (SBAR (WHNP-1 (WDT which)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBZ combines) (NP (NP (DT the) (NN tissue) (NN specificity)) (PP (IN of) (NP (DT any) (ADJP (NN Cre) (HYPH -) (JJ transgenic)) (NN line)))) (PP (IN with) (NP (NP (DT the) (NN inducibility)) (PP (IN of) (NP (DT the) (ADJP (NP (NP (NP (JJ reverse) (NN tetracycline) (NN transactivator)) (-LRB- -LRB-) (NP (NN rtTA))) (-RRB- -RRB-) (HYPH /) (NP (NP (ADJP (NN tetracycline) (HYPH -) (JJ responsive)) (NN element)) (-LRB- -LRB-) (NP (NN tet) (HYPH -) (NN O)))) (-RRB- -RRB-) (HYPH -) (VBN driven)) (NNS transgenes)))))))))) (. .)) )
( (S (S-PRP (NP-SBJ-1 (-NONE- *PRO*)) (VP (TO To) (VP (VB ensure) (NP (JJ reliable) (NN rtTA) (NN expression)) (PP (IN in) (NP (NP (DT a) (JJ broad) (NN range)) (PP (IN of) (NP (NN cell) (NNS types)))))))) (, ,) (NP-SBJ-1 (PRP we)) (VP (VBP have) (VP (VBN targeted) (NP (DT the) (NN rtTA) (NN transgene)) (PP (IN into) (NP (DT the) (NN ROSA26) (NN locus))))) (. .)) )
( (S (NP-SBJ (DT The) (NN rtTA) (NN expression)) (, ,) (ADVP (RB however)) (, ,) (VP (VBZ is) (ADJP-PRD (JJ conditional) (PP (IN to) (NP (NP (DT a) (ADJP (NP (NN Cre) (NN recombinase)) (HYPH -) (VBN mediated)) (NN excision)) (PP (IN of) (NP (DT a) (NN STOP) (NN region))) (PP (IN from) (NP (DT the) (NN ROSA26) (NN locus))))))) (. .)) )
( (S (NP-SBJ (PRP We)) (VP (VBP demonstrate) (NP (NP (DT the) (NN utility)) (PP (IN of) (NP (DT this) (NN technology)))) (PP-MNR (IN through) (NP (NP (NP (DT the) (JJ inducible) (NN expression)) (PP (IN of) (NP (DT the) (NML (NML (JJ vascular) (JJ endothelial) (NN growth) (NN factor)) (-LRB- -LRB-) (NML (NN VEGF) (HYPH -) (NN A))) (-RRB- -RRB-))) (PP-TMP=1 (IN during) (NP (JJ embryonic) (NN development)))) (CC and) (NP (ADVP-TMP=1 (RB postnatally)) (PP-LOC (IN in) (NP (JJ adult) (NNS mice))))))) (. .)) )
( (S (NP-SBJ (NP (PRP$ Our) (NNS results)) (PP (IN of) (NP (JJ adult) (NN induction)))) (VP (VBP recapitulate) (NP (NP (JJ several) (JJ different) (UCP (ADJP (JJ hepatic)) (CC and) (NML (JJ immune) (NN cell))) (JJ pathological) (NNS phenotypes)) (VP (VBN associated) (NP (-NONE- *)) (PP (IN with) (NP (VBN increased) (JJ systemic) (NML (NN VEGF) (HYPH -) (NN A)) (NN protein) (NNS levels)))))) (. .)) )
( (S (NP-SBJ (DT This) (NN system)) (VP (MD will) (VP (VB be) (ADJP-PRD (JJ useful) (PP-PRP (IN for) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG studying) (NP (NP (NNS genes)) (SBAR (WHPP-1 (IN in) (WHNP (WDT which))) (S (NP-SBJ (NP (JJ temporal) (NN control)) (PP (IN of) (NP (NN expression)))) (VP (VBZ is) (ADJP-PRD (JJ necessary) (PP (IN for) (NP (NP (DT the) (NN discovery)) (PP (IN of) (NP (NP (DT the) (JJ full) (NN spectrum)) (PP (IN of) (NP (NNS functions)))))))) (PP-LOC-1 (-NONE- *T*)))))))))))) (. .)) )
( (S (NP-SBJ (DT The) (VBN presented) (NN approach)) (VP (VBZ abrogates) (NP (DT the) (NN need) (S (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB generate) (NP (ADJP (NN tissue) (HYPH -) (JJ specific)) (NN rtTA) (NNS transgenes)) (PP (IN for) (NP (NP (NNS tissues)) (SBAR (WHADVP-1 (WRB where)) (S (NP-SBJ (ADJP (RB well) (HYPH -) (VBN characterized)) (NN Cre) (NNS lines)) (ADVP-TMP (RB already)) (VP (VBP exist) (ADVP-LOC-1 (-NONE- *T*)))))))))))) (. .)) )
( (HEADING (NP (NN INTRODUCTION))) )
( (S (NP-SBJ-1 (NP (JJ Cellular) (NN diversity)) (PP-LOC (IN in) (NP (DT a) (VBG developing) (NN organism)))) (VP (VBZ is) (VP (VBN achieved) (NP-1 (-NONE- *)) (PP-MNR (IN by) (NP (NP (NP (ADJP (JJ spatial) (CC and) (JJ temporal)) (NN regulation)) (PP (IN of) (NP (NN gene) (NN expression)))) (VP (VBN determined) (NP (-NONE- *)) (PP-MNR (IN by) (NP (NP (JJ genetic) (NNS programs)) (CC and) (NP (JJ inductive) (NNS signals))))))))) (. .)) )
( (S (PP (IN As) (NP (DT a) (NN consequence))) (, ,) (NP-SBJ (NNS genes)) (VP (VBP have) (NP (NP (ADJP (ADVP (RB spatially) (CC and) (RB temporally)) (VBG acting)) (JJ multiple) (NNS functions)) (, ,) (SBAR (WHNP-1 (WDT which)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBP are) (ADJP-PRD (JJ difficult) (SBAR (WHNP-2 (-NONE- *0*)) (S (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB dissect) (NP-2 (-NONE- *T*)) (PP (IN without) (S-NOM (NP-SBJ (JJ proper) (JJ genetic) (NNS tools)) (VP (VBG providing) (NP (NP (JJ similar) (NN complexity)) (PP (IN of) (NP (NP (NP (NN control)) (PP (IN of) (NP (NN expression)))) (HYPH —) (NP (NP (NN disruption) (CC or) (NN overexpression)) (PP (IN of) (NP (NP (DT a) (NN gene)) (PP (IN of) (NP (NN interest))))))))))))))))))))) (PRN (-LRB- -LRB-) (NP (CD 1) (, ,) (CD 2)) (-RRB- -RRB-))) (. .)) )
( (S (NP-SBJ-1 (NP (JJ Uncontrolled) (JJ transgenic) (NN expression)) (PP (IN of) (NP (DT a) (JJ given) (NN gene))) (PP-LOC (PP (IN in) (NP (DT all) (NNS tissues))) (CC or) (PP (ADVP (RB even)) (IN in) (NP (VBN restricted) (NN cell) (NNS types))))) (VP (MD may) (VP (VB be) (VP (VBN associated) (NP-1 (-NONE- *)) (PP (IN with) (NP (NP (JJ embryonic) (NN lethality)) (SBAR (WHNP-2 (WDT that)) (S (NP-SBJ-2 (-NONE- *T*)) (VP (VBZ precludes) (NP (NP (JJ further) (NNS studies)) (PP (PP-TMP (IN at) (NP (NP (JJ later) (NNS stages)) (PP (IN of) (NP (NN development))))) (CC or) (PP-LOC (IN in) (NP (NNS adults))))))))))))) (. .)) )
( (S (NP-SBJ-1 (NP (ADJP (NP (NP (NN Cell) (NN type)) (SYM -) (HYPH /) (NP (NNS tissues))) (HYPH -) (JJ specific)) (NN mutation)) (PP (IN of) (NP (DT a) (NN gene)))) (VP (MD can) (VP (VB be) (VP (VBN achieved) (NP-1 (-NONE- *)) (PP-MNR (IN by) (NP (NP (DT a) (NML (CD two) (HYPH -) (NN step)) (NN process)) (: ;) (NP (NP (NP (NN introduction)) (PP (IN of) (NP (NN loxP) (NNS sites))) (PP (IN around) (NP (DT a) (ADJP (RB functionally) (JJ essential)) (JJ genomic) (NN part)))) (VP (VBN followed) (NP (-NONE- *)) (PP (IN by) (NP-LGS (NP (DT a) (ADJP (NP (NN cell) (NN type)) (HYPH -) (JJ specific)) (ADJP (NP (NN Cre) (NN recombinase)) (HYPH -) (VBN mediated)) (NN excision)) (PP (IN of) (NP (DT the) (ADJP (NN loxP) (VBN flanked)) (NN sequence)))))))))))) (. .)) )
( (S (NP-SBJ-1 (DT The) (JJ same) (NN strategy)) (VP (MD can) (VP (VB be) (VP (VBN used) (NP-1 (-NONE- *)) (PP-PRP (IN for) (NP (NP (ADJP (NP (NN cell) (NN type)) (HYPH -) (JJ specific)) (NN overexpression)) (PP (IN of) (NP (DT a) (NN transgene))))) (, ,) (SBAR-TMP (WHADVP-3 (WRB when)) (S (NP-SBJ-2 (DT a) (JJ strong) (JJ overall) (VBG expressing) (NN promoter)) (VP (VBZ is) (VP (VBN separated) (NP-2 (-NONE- *)) (PP (IN from) (NP (NP (DT the) (NN coding) (NN region)) (PP (IN of) (NP (NP (DT a) (NN gene)) (PP (IN of) (NP (NN interest))))))) (PP (IN by) (NP-LGS (ADJP (NN loxP) (VBN flanked)) (`` ‘) (NN STOP) ('' ’) (NNS sequences))) (ADVP-TMP-3 (-NONE- *T*)))))) (PRN (-LRB- -LRB-) (NP (NP (CD 1)) (, ,) (NP (NP (CD 3)) (PP (SYM –) (NP (CD 5))))) (-RRB- -RRB-))))) (. .)) )
( (S (PP (IN In) (NP (DT both) (NNS scenarios))) (, ,) (NP-SBJ (DT a) (NML (NN Cre) (NN recombinase)) (NN transgene)) (VP (VBZ provides) (NP (JJ spatial) (NN control))) (. .)) )
( (S (ADVP (RB However)) (, ,) (SBAR-TMP (IN once) (S (S (NP-SBJ-1 (NN Cre) (NN expression)) (VP (VBZ has) (VP (VBN been) (VP (VBN switched) (NP-1 (-NONE- *)) (PRT (RP on)))))) (CC and) (S (NP-SBJ (NN recombination)) (VP (VBZ has) (VP (VBN occurred)))))) (, ,) (NP-SBJ (NP (DT the) (JJ resultant) (NN change)) (PP (IN in) (NP (NN gene) (NN expression)))) (VP (VBZ is) (, ,) (PP (IN in) (NP (JJS most) (NNS cases))) (, ,) (ADJP-PRD (JJ irreversible))) (. .)) )
( (S (NP-SBJ (NP (ADJP (NN Tetracycline) (HYPH -) (JJ inducible)) (JJ transgenic) (NNS systems)) (-LRB- [) (NP (NP (NP (NP (NN tetracycline) (NN transactivator)) (-LRB- -LRB-) (NP (NN tTA))) (-RRB- -RRB-) (CC or) (`` ‘) (NP (NN Tet) (HYPH -) (NN Off))) ('' ’) (CC and) (NP (NP (NP (JJ reverse) (NN tetracycline) (NN transactivator)) (-LRB- -LRB-) (NP (NN rtTA))) (-RRB- -RRB-) (CC or) (`` ‘) (NP (NN Tet) (HYPH -) (NN On))))) ('' ’) (-RRB- ]) (VP (VBP allow) (PP (IN for) (NP (NP (JJ reversible) (JJ temporal) (NN regulation)) (PP (IN of) (NP (NN transgene) (NN expression))))) (PRN (-LRB- -LRB-) (NP (CD 6) (, ,) (CD 7)) (-RRB- -RRB-))) (. .)) )
( (S (PP-TPC-2 (IN Of) (NP (DT the) (CD two) (NNS systems))) (, ,) (NP-SBJ-1 (NP (NN rtTA)) (PP-2 (-NONE- *T*))) (VP (VBZ is) (ADJP-PRD (RBR better) (JJ suited) (PP (IN for) (NP (NP (JJ rapid) (NN induction)) (PP (IN of) (NP (NN gene) (NN expression))))))) (. .)) )
( (S (PP (IN In) (NP (DT the) (VBG following) (NN report))) (, ,) (NP-SBJ (PRP we)) (VP (VBP describe) (NP (NP (DT a) (JJ novel) (NN system)) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBZ allows) (PP (IN for) (NP (NP (DT the) (ADJP (JJ spatial) (CC and) (JJ temporal)) (NN regulation)) (PP (IN of) (NP (NN transgene) (NN expression))) (ADVP-LOC (FW in) (FW vivo)))) (PP-MNR (IN by) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG combining) (NP (NP (DT any)) (PP (IN of) (NP (DT the) (VBG existing) (NML (NN Cre) (NN recombinase)) (JJ transgenic) (NNS lines)))) (PP (IN with) (NP (DT the) (NML (NML (NML (JJ reverse) (NN tTA)) (-LRB- -LRB-) (NML (NN rtTA))) (-RRB- -RRB-) (, –) (NML (NN tet) (HYPH -) (NN O))) (NN system))))))))))) (. .)) )
( (S (NP-SBJ (PRP We)) (VP (VBD targeted) (NP (NN rtTA)) (PP (IN into) (NP (DT the) (ADJP (RB widely) (VBN expressed)) (NN ROSA26) (NN locus))) (, ,) (PP-MNR (IN in) (NP (NP (DT a) (NN way)) (SBAR (WHADVP-1 (WRB where)) (S (NP-SBJ (NN rtTA) (NN expression)) (VP (VBZ is) (ADJP-PRD (JJ conditional) (PP (IN to) (NP (DT a) (ADJP (NN Cre) (HYPH -) (VBN mediated)) (NN excision) (NN event)))) (ADVP-MNR-1 (-NONE- *T*))))))) (PRN (-LRB- -LRB-) (NP (CD 8)) (-RRB- -RRB-))) (. .)) )
( (S (ADVP (RB Furthermore)) (, ,) (NP-SBJ (PRP we)) (VP (VBP demonstrate) (NP (NP (DT the) (NML (NN tightness) (CC and) (NN inducibility))) (PP (IN of) (NP (DT this) (NN approach)))) (PP-MNR (IN by) (NP (NP (ADJP (ADJP (JJ systemic)) (CC and) (ADJP (NP (NN cell) (NN type)) (HYPH -) (JJ specific))) (PRN (-LRB- -LRB-) (UCP (JJ neuronal) (CC and) (NN podocyte)) (-RRB- -RRB-)) (JJ inducible) (NN expression)) (PP (IN of) (NP (NP (DT a) (ADJP (NN dosage) (HYPH -) (JJ sensitive)) (NN gene)) (, ,) (NP (NN VEGF) (HYPH -) (NN A)))))) (PRN (-LRB- -LRB-) (NP (CD 9)) (-RRB- -RRB-))) (. .)) )
( (S (NP-SBJ-1 (DT The) (VBN presented) (NN mouse) (NN line)) (VP (MD can) (VP (VB be) (VP (VBN used) (NP-1 (-NONE- *)) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB achieve) (NP (ADJP (ADVP (RB spatially) (CC and) (RB temporally)) (VBN controlled)) (NN transgene) (NN expression)) (PP (IN in) (NP (NP (DT a) (JJ wide) (NN variety)) (PP (IN of) (NP (NNS settings))))) (PP-MNR (ADVP (RB simply)) (IN by) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG crossing) (PP (IN to) (NP (NP (DT any) (VBG existing) (NNS mice)) (VP (VBG carrying) (NP (NP (ADJP (NP (NN cell) (NN type)) (HYPH -) (JJ specific)) (NN Cre) (NN recombinase)) (CC and) (NP (ADJP (NP (NN tet) (HYPH -) (NN O)) (HYPH -) (JJ regulatable)) (NN responder) (NNS genes))))))))))))))) (. .)) )
( (HEADING (NP (NNS MATERIALS) (CC AND) (NNS METHODS))) )
( (HEADING (NP (NN DNA) (NNS constructs))) )
( (S (NP-SBJ-1 (NP (DT An) (NN EcoRI) (NN fragment)) (VP (VBG carrying) (NP (NP (DT the) (NN rtTA) (NN coding) (NN sequence)) (CC and) (NP (DT an) (ADJP (NN N) (HYPH -) (JJ terminal)) (NML (JJ nuclear) (NN localization)) (NN signal))))) (VP (VBD was) (VP (VP (VBN excised) (NP-1 (-NONE- *)) (PP (IN from) (NP (NP (DT the) (NN plasmid)) (NP (NN pSPC) (HYPH -) (NN rtTA)))) (PRN (-LRB- -LRB-) (NP (CD 10)) (-RRB- -RRB-))) (, ,) (VP (VBN blunted) (NP-1 (-NONE- *)) (PP (IN by) (NP-LGS (NN Klenow) (NN enzyme)))) (CC and) (VP (VBN inserted) (NP-1 (-NONE- *)) (PP (IN into) (NP (DT the) (NML (NN pCALL2) (HYPH -) (NN IRES) (HYPH -) (NN EGFP)) (NN plasmid) (PRN (-LRB- -LRB-) (NP (NP (DT a) (NN gift)) (PP (IN from) (NP (NNP Dr) (NNP Corrine) (NNP Lobe)))) (-RRB- -RRB-)))) (PP-LOC (IN at) (NP (DT a) (JJ blunted) (NN XhoI) (NN site)))))) (. .)) )
( (S (S (NP-SBJ-1 (NP (DT The) (NN resultant) (NN vector)) (-LRB- -LRB-) (NP (NN pCALL2) (HYPH -) (NN rtTA) (HYPH -) (NN IRES) (HYPH -) (NN EGFP)) (-RRB- -RRB-)) (VP (VBD was) (VP (ADVP-TMP (RB first)) (VBN digested) (NP-1 (-NONE- *)) (PP-MNR (IN with) (NP (NN BglII)))) (, ,) (VP (VBN filled) (NP-1 (-NONE- *)) (PRT (RP in)) (PP (IN by) (NP-LGS (NN Klenow) (NN polymerase)))) (CC and) (VP (ADVP-TMP (RB then)) (VBN cut) (NP-1 (-NONE- *)) (PP-MNR (IN with) (NP (NN NotI)))))) (, ,) (CC and) (S (NP-SBJ-2 (NP (DT the) (NN fragment)) (VP (VBG containing) (NP (NN rtTA) (HYPH -) (NN IRES) (HYPH -) (NN EGFP)))) (VP (VBD was) (VP (VBN isolated) (NP-2 (-NONE- *))))) (. .)) )
( (S (NP-SBJ-1 (DT The) (NN pBigT) (NN vector) (PRN (-LRB- -LRB-) (NP (CD 11)) (-RRB- -RRB-))) (VP (VBD was) (VP (VP (VBN digested) (NP-1 (-NONE- *)) (ADVP-TMP (RB first)) (PP-MNR (IN with) (NP (NN SalI)))) (, ,) (VP (VBN filled) (NP-1 (-NONE- *)) (PRT (RP in))) (CC and) (VP (ADVP-TMP (RB subsequently)) (VBN digested) (NP-1 (-NONE- *)) (PP-MNR (IN with) (NP (NN NotI)))))) (. .)) )
( (S (NP-SBJ-1 (DT The) (JJ above) (NN fragment)) (VP (VBD was) (VP (VBN inserted) (NP-1 (-NONE- *)) (PP (IN into) (NP (DT this) (NN vector))) (S-ADV (NP-SBJ (-NONE- *PRO*)) (VP (VBG resulting) (PP (IN in) (NP (NN pBigT) (HYPH -) (NN rtTA) (HYPH -) (NN IRES) (HYPH -) (NN EGFP))))))) (. .)) )
( (S (NP-SBJ-1 (NP (DT The) (JJ whole) (NN insert)) (PP (IN of) (NP (DT the) (JJ latter) (NN vector)))) (VP (VP (VBD was) (VP (VBN released) (NP-1 (-NONE- *)) (PP (IN by) (NP-LGS (NML (NN AscI) (HYPH –) (NN PacI)) (JJ double) (NN digest))))) (CC and) (VP (VBN inserted) (NP-1 (-NONE- *)) (PP (IN into) (NP (NP (NML (NN pROSA26) (HYPH -) (NN PA)) (NN vector) (PRN (-LRB- -LRB-) (NP (CD 11)) (-RRB- -RRB-))) (VP (VBN digested) (NP (-NONE- *)) (PP (IN by) (NP-LGS (DT the) (JJ same) (NNS enzymes)))))))) (. .)) )
( (S (NP-SBJ-1 (DT The) (NN resultant) (NN target) (NN vector)) (VP (VBD was) (VP (VBN named) (NP-1 (-NONE- *)) (S-CLR (NP-SBJ-1 (-NONE- *PRO*)) (NP-PRD (NN pROSA26) (HYPH -) (NN rtTA))) (PRN (-LRB- -LRB-) (NP (NN Figure) (CD 1A)) (-RRB- -RRB-)))) (. .)) )
( (S (PP-TMP (IN Before) (NP (NP (NN introduction)) (PP (IN into) (NP (NN mouse) (NML (NML (JJ embryonic) (NN stem)) (-LRB- -LRB-) (NML (NN ES))) (-RRB- -RRB-) (NNS cells))))) (, ,) (NP-SBJ-1 (DT the) (NN vector)) (VP (VBD was) (VP (VBN linearized) (NP-1 (-NONE- *)) (PP-MNR (IN with) (NP (NN XhoI))))) (. .)) )
( (S (NP-SBJ-1 (DT The) (JJ murine) (NN podocin) (NN promoter)) (VP (VBD was) (VP (VP (VBN amplified) (NP-1 (-NONE- *)) (PP (IN from) (NP (JJ genomic) (JJ murine) (NN DNA))) (SBAR-ADV (IN as) (S (NP-SBJ-2 (-NONE- *PRO*)) (VP (VBN described) (NP-2 (-NONE- *)) (ADVP-TMP (RB previously)) (PRN (-LRB- -LRB-) (NP (CD 12)) (-RRB- -RRB-)))))) (CC and) (VP (VBN cloned) (NP-1 (-NONE- *)) (ADVP-LOC (RB upstream) (PP (IN of) (NP (DT the) (NML (NN NLS) (HYPH -) (NN Cre)) (NN transgene) (PRN (-LRB- -LRB-) (NP (NP (DT a) (NN gift)) (PP (IN from) (NP (NNP B.) (NNP Sauer)))) (-RRB- -RRB-)))))))) (. .)) )
( (HEADING (NP (NML (NN ES) (NN cell)) (NN manipulation))) )
( (S (NP-SBJ-1 (NN R1) (NN mouse) (NN ES) (NNS cells) (PRN (-LRB- -LRB-) (NP (CD 13)) (-RRB- -RRB-))) (VP (VBD were) (VP (VBN maintained) (CC and) (VBN manipulated) (NP-1 (-NONE- *)) (SBAR-ADV (IN as) (S (NP-SBJ-2 (-NONE- *PRO*)) (VP (VBN described) (NP-2 (-NONE- *)) (ADVP (RB elsewhere))))) (PRN (-LRB- -LRB-) (NP (CD 14)) (-RRB- -RRB-)))) (. .)) )
( (S (PP (IN In) (ADJP (JJ brief))) (, ,) (NP-SBJ-1 (NP (CD 20) (NN μg)) (PP (IN of) (NP (VBN linearized) (NN target) (NN vector)))) (VP (VBD was) (VP (VBN electroporated) (NP-1 (-NONE- *)) (PP (IN into) (NP (CD 107) (NNS cells))) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (NP (NML (NML (CD 500) (NN μF)) (CC and) (NML (CD 250) (NN V))) (NNS settings)) (PP (IN on) (NP (NNP Gene) (NNP Pulser) (PRN (-LRB- -LRB-) (NP (NNP Bio) (HYPH -) (NNP Rad)) (-RRB- -RRB-))))))))) (. .)) )
( (S (PP-TMP (IN After) (NP (CD 24) (NN h))) (, ,) (NP-SBJ-1 (DT the) (NNS cells)) (VP (VBD were) (VP (VBN selected) (NP-1 (-NONE- *)) (PP-PRP (IN for) (NP (NN neomycin) (NN resistance))) (PP-LOC (IN in) (NP (NN G418) (PRN (-LRB- -LRB-) (NP (NP (CD 170) (NN μg)) (PP (SYM /) (NP (NN ml)))) (-RRB- -RRB-)))) (PP-TMP (IN for) (NP (CD 8) (NNS days))))) (. .)) )
( (S (S (NP-SBJ-1 (DT The) (JJ resistant) (NNS colonies)) (VP (VBD were) (VP (VP (VBN picked) (NP-1 (-NONE- *))) (, ,) (VP (VBN expanded) (NP-1 (-NONE- *))) (CC and) (VP (VBN split) (NP-1 (-NONE- *)) (PP (IN in) (NP (NML (CD 96) (HYPH -) (NN well)) (NNS plates))))))) (, ,) (CC and) (S (NP-SBJ-2 (DT the) (NN master) (NNS plates)) (VP (VBD were) (VP (VP (VBN frozen) (NP-2 (-NONE- *))) (CC and) (VP (VBN stored) (NP-2 (-NONE- *)) (PP (IN at) (NP (QP (SYM −) (CD 80)) (NN °C))) (SBAR-TMP (IN until) (S (NP-SBJ (JJ genetic) (NN characterization)) (VP (VBD identified) (NP (DT the) (ADJP (RB correctly) (VBN targeted)) (NNS clones))))))))) (. .)) )
( (S (NP-SBJ-1 (NP (DT Some)) (PP (IN of) (NP (DT these) (VBN targeted) (NNS clones)))) (VP (VBD were) (VP (VP (VBN thawed) (NP-1 (-NONE- *)) (PP (IN from) (NP (DT the) (NN master) (NNS plates)))) (, ,) (VP (VBN expanded) (NP-1 (-NONE- *))) (CC and) (VP (VBN subjected) (NP-1 (-NONE- *)) (PP (IN to) (NP (NP (JJ further) (NNS procedures)) (VP (VBN described) (NP (-NONE- *)) (ADVP (RB below)))))))) (. .)) )
( (S (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO To) (VP (VB activate) (NP (NN rtTA) (NN expression)) (PP (IN from) (NP (DT the) (NN ROSA26) (NN locus)))))) (, ,) (NP-SBJ-1 (NP (DT the) (NN transfection)) (PP (IN of) (NP (DT the) (VBN selected) (VBN targeted) (NNS clones))) (PP (IN with) (NP (DT the) (NML (NN pCAGGS) (HYPH -) (NN Cre) (HYPH -) (NN PGK) (HYPH -) (NN puro)) (NN vector) (PRN (-LRB- -LRB-) (NP (NP (DT a) (NN gift)) (PP (IN from) (NP (NNP C.) (NNP Lobe)))) (-RRB- -RRB-))))) (VP (VBD was) (VP (VBN performed) (NP-1 (-NONE- *)) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (NN Lipofectamine) (CD 2000) (PRN (-LRB- -LRB-) (NP (NNP Invitrogen)) (-RRB- -RRB-))))))) (. .)) )
( (S (NP-SBJ-1 (NP (DT An) (NN aliquot)) (PP (IN of) (NP (NML (CD 2) (NN μg)) (JJ circular) (NN plasmid)))) (VP (VBD was) (VP (VBN transfected) (NP-1 (-NONE- *)) (PP (IN into) (NP (NP (NNS cells)) (VP (VBG growing) (PP (IN in) (NP (DT a) (NML (NML (CD 35) (NN mm)) (NN diameter)) (NN dish)))))))) (. .)) )
( (S (PP-TMP (IN During) (NP (DT the) (NN transfection))) (, ,) (NP-SBJ-1 (NML (NN OPTI) (HYPH -) (NN MEM)) (NN medium)) (VP (VBD was) (VP (VBN used) (NP-1 (-NONE- *)))) (. .)) )
( (S (S (NP-SBJ-1=4 (NN Puromycin) (NN selection) (PRN (-LRB- -LRB-) (NP (NP (CD 1.25) (NN μg)) (PP (SYM /) (NP (NN ml)))) (-RRB- -RRB-))) (VP (VBD was) (VP=3 (VBN applied) (NP-1 (-NONE- *))))) (, ,) (CC and) (S (NP-SBJ-2=4 (JJ resistant) (NNS colonies)) (VP=3 (VBN expanded) (NP-2 (-NONE- *)))) (. .)) )
( (S (NP-SBJ-1 (JJ Green) (NN fluorescence)) (VP (VBD was) (VP (VBN detected) (NP-1 (-NONE- *)) (SBAR-ADV (IN as) (S (NP-SBJ-2 (-NONE- *PRO*)) (VP (VBN described) (NP-2 (-NONE- *)) (ADVP-TMP (RB previously))))) (PRN (-LRB- -LRB-) (NP (CD 15)) (-RRB- -RRB-)))) (. .)) )
( (S (NP-SBJ (DT The) (NML (NN pBI) (HYPH -) (CD 3)) (NN plasmid) (PRN (-LRB- -LRB-) (NP (NP (DT a) (NN gift)) (PP (IN from) (NP (NNP H.) (NNP Bujard)))) (-RRB- -RRB-))) (VP (VBZ contains) (NP (NP (DT a) (JJ bi-directional) (ADJP (NN tetracycline) (HYPH -) (JJ responsive)) (NN element)) (VP (VBN followed) (NP (-NONE- *)) (PP (IN by) (NP-LGS (DT the) (NN lacZ) (NN coding) (NN sequence)))))) (. .)) )
( (S (NP-SBJ-1 (DT This) (NN vector)) (VP (VBD was) (VP (VBN introduced) (NP-1 (-NONE- *)) (PP (IN into) (NP (NN ES) (HYPH -) (NNS cells))) (PP-MNR (IN by) (NP (NN lipofection))) (PP-MNR (VBG according) (PP (IN to) (NP (NP (DT the) (NN protocol)) (ADVP (RB above))))))) (. .)) )
( (S (PP-TMP (IN After) (NP (NP (CD 5) (NN h)) (PP (IN of) (NP (NN transfection))))) (, ,) (NP-SBJ-1 (NN doxycycline) (PRN (-LRB- -LRB-) (NP (NNP Sigma)) (-RRB- -RRB-))) (VP (VBD was) (VP (VBN added) (NP-1 (-NONE- *)) (PP (IN to) (NP (DT the) (NN medium))) (PP (IN in) (NP (VBG differing) (NNS concentrations))))) (. .)) )
( (S (NP-TMP (NP (DT The) (NN day)) (PP (IN after) (NP (NN lipofection)))) (, ,) (NP-SBJ-1 (DT the) (NNS cells)) (VP (VBD were) (VP (VP (VP (VBN passaged) (NP-1 (-NONE- *)) (NP-ADV (NP (CD 1)) (PP (SYM :) (NP (CD 5))))) (CC and) (VP (VBN cultured) (NP-1 (-NONE- *)) (PP-TMP (IN for) (NP (DT a) (JJ further) (QP (CD 1) (SYM –) (CD 2)) (NNS days))) (PP (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NN doxycyline) (PRN (-LRB- -LRB-) (NP (NP (CD 100) (NN ng)) (PP (SYM /) (NP (NN ml)))) (-RRB- -RRB-)))))))) (, ,) (CC and) (VP (ADVP-TMP (RB then)) (VBN stained) (NP-1 (-NONE- *)) (PP-MNR (IN by) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (NN X) (HYPH -) (NN gal)))))))) (. .)) )
( (HEADING (NP (NP (NN Generation)) (PP (IN of) (NP (JJ transgenic) (NNS animals))))) )
( (S (NP-SBJ-1 (JJ Chimeric) (NNS mice)) (VP (VBD were) (VP (VBN generated) (NP-1 (-NONE- *)) (PP-MNR (IN by) (NP (NP (NN aggregation)) (PP (IN of) (NP (VBN targeted) (NN ES) (HYPH -) (NNS cells))) (PP (IN with) (NP (NML (NML (CD eight) (HYPH -) (NN cell)) (NN stage)) (NNS embryos))))) (SBAR-ADV (IN as) (S (NP-SBJ-2 (-NONE- *PRO*)) (VP (VBN described) (NP-2 (-NONE- *)) (ADVP-TMP (RB previously))))) (PRN (-LRB- -LRB-) (NP (CD 16)) (-RRB- -RRB-)))) (. .)) )
( (S (S (NP-SBJ-1 (ADJP (NN Germline) (VBG transmitting)) (JJ chimeric) (NNS males)) (VP (VBD were) (VP (VBN crossed) (NP-1 (-NONE- *)) (PP (IN with) (NP (JJ outbred) (NN ICR) (NNS females)))))) (CC and) (S (NP-SBJ-2 (DT the) (NN offspring)) (VP (VBD were) (VP (VBN genotyped) (NP-2 (-NONE- *)) (PP-MNR (IN by) (NP (NP (NNP Southern) (NN blotting)) (CC and) (NP (NN PCR)))) (PP-PRP (IN for) (NP (NP (DT the) (NN transmission)) (PP (IN of) (NP (DT the) (NN transgene)))))))) (. .)) )
( (S (NP-SBJ-1 (DT The) (NML (NN Cre) (HYPH -) (NN recombinase)) (JJ transgenic) (NN founder) (NNS lines)) (VP (VBD were) (VP (VBN generated) (NP-1 (-NONE- *)) (SBAR-ADV (IN as) (S (NP-SBJ-2 (-NONE- *PRO*)) (VP (VBN described) (NP-2 (-NONE- *)) (ADVP-TMP (RB previously))))) (PRN (-LRB- -LRB-) (NP (CD 17)) (-RRB- -RRB-)))) (. .)) )
( (S (PP (VBG Regarding) (NP (DT the) (NML (NN Podocin) (HYPH -) (NN Cre)) (NN transgene))) (NP-SBJ-1 (CD four) (JJ individual) (NN founder) (NNS lines)) (VP (VBD were) (VP (VBN crossed) (NP-1 (-NONE- *)) (PP (IN with) (NP (DT the) (NML (NN Z) (HYPH /) (NN EG)) (NN reporter) (NN strain) (PRN (-LRB- -LRB-) (NP (CD 15)) (-RRB- -RRB-)))) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB determine) (NP (NP (DT the) (NML (NN degree) (CC and) (NN timing))) (PP (IN of) (NP (ADJP (NN Cre) (HYPH -) (VBN mediated)) (NN DNA) (NN excision)))) (PP-LOC (IN in) (NP (NNS podocytes)))))))) (. .)) )
( (HEADING (NP (NP (NN Genotyping)) (PP (IN by) (NP (NNP Southern) (NN blotting))))) )
( (S (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO To) (VP (VB detect) (NP (NP (NN targeting)) (PP (IN of) (NP (DT the) (NN ROSA26) (NN locus))))))) (, ,) (S (S (NP-SBJ-1=2 (JJ genomic) (NN DNA)) (VP (VBD was) (VP=4 (VP (VBN isolated) (NP-1 (-NONE- *)) (PP (IN from) (NP (NP (DT the) (NN ES) (NNS cells)) (VP (VBN grown) (NP (-NONE- *)) (PP (IN on) (NP (NML (CD 96) (HYPH -) (NN well)) (NNS plates)))))) (PRN (-LRB- -LRB-) (NP (CD 18)) (-RRB- -RRB-))) (, ,) (VP (VBN digested) (NP-1 (-NONE- *)) (PP-MNR (IN with) (NP (NN EcoRV))))))) (CC and) (S (NP-SBJ-3=2 (DT the) (NNS fragments)) (VP=4 (VBN separated) (NP-3 (-NONE- *)) (PP-LOC (IN on) (NP (NML (CD 0.7) (NN %)) (NN agarose) (NN gel)))))) (. .)) )
( (S (NP-SBJ-1 (NNP Southern) (NN blotting)) (VP (VBD was) (VP (VBN performed) (NP-1 (-NONE- *)) (SBAR-ADV (IN as) (S (NP-SBJ-2 (-NONE- *PRO*)) (VP (VBN described) (NP-2 (-NONE- *)) (ADVP-TMP (RB previously))))) (PRN (-LRB- -LRB-) (NP (CD 19)) (-RRB- -RRB-)))) (. .)) )
( (S (ADVP-TMP (RB Briefly)) (, ,) (NP-SBJ-1 (DT the) (NN DNA)) (VP (VBD was) (VP (VP (VBN transferred) (NP-1 (-NONE- *)) (PP (IN onto) (NP (DT a) (NN nitrocellulose) (NN membrane) (PRN (-LRB- -LRB-) (NP (NNP Hybond) (NNP N)) (: ;) (NP (NNP Amersham)) (-RRB- -RRB-))))) (CC and) (VP (VBN hybridized) (NP-1 (-NONE- *)) (PP-MNR (PP (IN with) (NP (NP (DT a) (NN probe)) (ADJP (JJ complementary) (PP (IN to) (NP (NP (DT a) (NN sequence)) (ADVP-LOC (RB upstream) (PP (IN of) (NP (NP (DT the) (NML (CD 5) (SYM ′)) (NN homology) (NN arm)) (PP (IN of) (NP (DT the) (NN vector)))))) (PRN (-LRB- -LRB-) (NP (JJ external) (NN probe)) (-RRB- -RRB-))))))) (CC or) (PP (IN with) (NP (NP (DT a) (NN probe)) (ADJP (JJ complementary) (PP (IN to) (NP (DT the) (NN neo) (NN gene))) (PRN (-LRB- -LRB-) (NP (JJ internal) (NN probe)) (-RRB- -RRB-)))))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NML (NN 1A) (CC and) (NN B))) (-RRB- -RRB-))))) (. .)) )
( (S (NP-SBJ-1 (DT The) (JJ radioactive) (NN signal)) (VP (VBD was) (VP (VBN detected) (NP-1 (-NONE- *)) (PP-MNR (IN by) (NP (NN phosphorimaging))))) (. .)) )
( (S (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO To) (VP (VB detect) (NP (DT the) (NN mutation)) (PP-LOC (IN in) (NP (NNS mice)))))) (, ,) (NP-SBJ-1 (NML (CD 10) (NN μg)) (JJ genomic) (NN DNA)) (VP (VBD was) (VP (VP (VP (VBN extracted) (NP-1 (-NONE- *)) (PP (IN from) (NP (NML (NN mouse) (NN tail)) (NNS biopsies)))) (CC and) (VP (VBN analyzed) (NP-1 (-NONE- *)) (PP-MNR (IN by) (NP (NNP Southern) (NN hybridization))))) (PP (IN as) (ADVP (RB above))))) (. .)) )
( (HEADING (NP (NP (NN Genotyping)) (PP (IN by) (NP (NN PCR))))) )
( (S (NP-SBJ-1 (NN PCR)) (VP (VBD was) (VP (VBN performed) (NP-1 (-NONE- *)) (PP-MNR (IN in) (NP (NP (NML (CD 25) (NN μl)) (NN reaction) (NN mixture)) (VP (VBG containing) (NP (NP (JJ standard) (NN PCR) (NN buffer)) (, ,) (NP (NML (CD 1.0) (NN mM)) (NN MgCl2)) (, ,) (NP (NML (CD 200) (NN μM)) (NNS dNTPs)) (, ,) (NP (NML (CD 200) (NN nM)) (NNS primers)) (, ,) (NP (NML (CD 5) (NN U)) (NNP Taq) (NN polymerase)) (CC and) (NP (NP (NML (CD 100) (NN ng)) (JJ genomic) (NN DNA)) (VP (VBN isolated) (NP (-NONE- *)) (PP (IN from) (NP (NML (NN mouse) (NN ear)) (NNS biopsies))))))))))) (. .)) )
( (FRAG (S (NP-SBJ (NP (DT The) (NNS primers)) (PP (IN for) (NP (NP (NN detection)) (PP (IN of) (NP (NP (DT the) (VBN targeted) (NN ROSA26) (NN allele)) (VP (VBG containing) (NP (DT the) (NN STOP) (NN cassette)))))))) (VP (VBD were) (SBAR-PRD (IN as) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (VBZ follows) (NP-1 (-NONE- *))))))) (: :) (NP (NP (NP (NN ROSA5)) (, ,) (NP (NN GAGTTCTCTGCTGCCTCCTG))) (: ;) (CC and) (NP (NP (NN RTTA3)) (, ,) (NP (NN AAGACCGCGAAGAGTTTGTC)))) (. .)) )
( (S (NP-SBJ (DT The) (NN reaction)) (VP (VBD resulted) (PP (IN in) (NP (DT a) (NML (CD 215) (NN bp)) (NN band)))) (. .)) )
( (S (NP-SBJ-1 (DT The) (NML (JJ wild) (HYPH -) (NN type)) (NN ROSA26) (NN allele)) (VP (VBD was) (VP (VBN detected) (NP-1 (-NONE- *)) (PP-MNR (IN by) (NP (NP (DT an) (NN amplicon)) (PP (IN of) (NP (CD 322) (NN bp))))) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (NP (NNS primers) (NML (NN ROSA5) (CC and) (NN ROSA3))) (: :) (NP (NN CGAGGCGGATACAAGCAATA))))))) (. .)) )
( (FRAG (S (NP-SBJ (DT The) (NN PCR) (NN program)) (VP (VBD was) (SBAR-PRD (IN as) (S (NP-SBJ (-NONE- *PRO*)) (VP (VBZ follows)))))) (: :) (NP (NP (NP (JJ initial) (NN denaturation)) (PP-TMP (IN for) (NP (CD 1) (NN min))) (PP (IN at) (NP (CD 94) (NN °C)))) (VP (VBN followed) (NP (-NONE- *)) (PP (IN by) (NP-LGS (NP (NP (CD 35) (NNS cycles)) (PP (IN of) (NP=2 (CD 1) (NN min))) (PP=1 (IN at) (NP (CD 94) (NN °C)))) (, ,) (NP (NP=2 (CD 45) (NN s)) (PP=1 (IN at) (NP (NP (CD 62) (NN °C) (PRN (-LRB- -LRB-) (NP (ADJP (VB knock) (HYPH -) (RP in)) (NN allele)) (-RRB- -RRB-))) (CC or) (NP (CD 64) (NN °C) (PRN (-LRB- -LRB-) (NP (NML (JJ wild) (HYPH -) (NN type)) (NN allele)) (-RRB- -RRB-)))))) (CC and) (NP (NP=2 (CD 1) (NN min)) (PP=1 (IN at) (NP (CD 72) (NN °C))))) (CC and) (NP (NP (DT a) (JJ final) (NN extension)) (PP-TMP (IN of) (NP (CD 5) (NN min))) (PP (IN at) (NP (CD 72) (NN °C))))))) (. .)) )
( (S (NP-SBJ-1 (NN PCR) (NNS products)) (VP (VBD were) (VP (VBN detected) (NP-1 (-NONE- *)) (PP-LOC (IN on) (NP (NML (CD 2) (NN %)) (NN agarose) (NN gel))))) (. .)) )
( (HEADING (NP (NN Histology))) )
( (S (NP-SBJ-1 (NP (DT The) (NML (NN X) (HYPH -) (NN gal)) (NN staining)) (PP (IN of) (NP (NN ES) (NNS cells)))) (VP (VBD was) (VP (VBN performed) (NP-1 (-NONE- *)) (SBAR-ADV (IN as) (S (NP-SBJ-2 (-NONE- *PRO*)) (VP (VBN described) (NP-2 (-NONE- *)) (ADVP-TMP (RB previously))))) (PRN (-LRB- -LRB-) (NP (CD 15)) (-RRB- -RRB-)))) (. .)) )
( (S (NP-SBJ-1 (ADJP (JJ Embryonic) (CC and) (JJ adult)) (NN tissue) (NNS samples)) (VP (VBD were) (VP (VP (VBN dissected) (NP-1 (-NONE- *))) (CC and) (VP (VBN fixed) (NP-1 (-NONE- *)) (ADVP-TMP (RB overnight)) (PP-LOC (IN in) (NP (NML (CD 4) (NN %)) (NN PFA)))))) (. .)) )
( (S (NP-TMP (DT The) (VBG following) (NN day)) (, ,) (NP-SBJ-1 (DT the) (NNS samples)) (VP (VBD were) (VP (VP (VP (VBN washed) (NP-1 (-NONE- *)) (ADVP (RB extensively)) (PP-MNR (IN with) (NP (QP (CD 1) (SYM ×)) (NN PBS)))) (, ,) (VP (VBN dehydrated) (NP-1 (-NONE- *)) (PP-MNR (IN through) (NP (NML (JJ graded) (NN alcohol)) (NNS washes)))) (CC and) (VP (VBN embedded) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NN paraffin) (NN wax))))) (SBAR-ADV (IN as) (S (NP-SBJ-2 (-NONE- *PRO*)) (VP (VBN described) (NP-2 (-NONE- *)) (ADVP-TMP (RB previously))))) (PRN (-LRB- -LRB-) (NP (CD 20)) (-RRB- -RRB-)))) (. .)) )
( (S (NP-SBJ-1 (NNS Sections) (PRN (-LRB- -LRB-) (NP (CD 7) (NN μm)) (-RRB- -RRB-))) (VP (VBD were) (VP (VP (VBN deparaffinized) (NP-1 (-NONE- *))) (CC and) (VP (VBN stained) (NP-1 (-NONE- *)) (PP-MNR (IN with) (NP (NP (NP (NNP Harris) (POS ')) (NN Hematoxylin)) (CC and) (NP (NN Eosin)) (PRN (-LRB- -LRB-) (NP (NNP Sigma) (NNP Immunochemicals)) (-RRB- -RRB-))))))) (. .)) )
( (HEADING (NP (NNS RESULTS) (CC AND) (NN DISCUSSION))) )
( (HEADING (NP (NP (NN Generation)) (PP (IN of) (NP (DT the) (NML (NN ROSA26) (HYPH -) (NN rtTA)) (ADJP (VB knock) (HYPH -) (RP in)) (NML (NN ES) (NN cell)) (NN line))))) )
( (S (NP-SBJ (PRP We)) (VP (VBD inserted) (NP (DT an) (JJ artificial) (NN exon)) (PP-LOC (IN between) (NP (NP (NP (DT the) (JJ first) (NML-1 (-NONE- *RNR*))) (CC and) (NP (DT the) (JJ second) (NML-1 (-NONE- *RNR*))) (NML-1 (NNS exons))) (PP (IN of) (NP (DT the) (NN mouse) (NN ROSA26) (NN locus))))) (PP-MNR (IN by) (NP (NN gene) (HYPH -) (VBG targeting)))) (. .)) )
( (S (PP-TPC-2 (IN Of) (NP (NP (DT the) (CD 140) (ADJP (NN G418) (JJ resistant)) (NNS colonies)) (VP (VBN picked) (CC and) (VBN genotyped) (NP (-NONE- *))))) (, ,) (NP-SBJ-1 (NP (NP (CD 12)) (-LRB- -LRB-) (NP (CD 8) (NN %))) (PP-2 (-NONE- *T*))) (-RRB- -RRB-) (VP (VBD were) (ADVP (RB correctly)) (VP (VBN targeted) (NP-1 (-NONE- *)) (PRN (-LRB- -LRB-) (NN Figure) (NML (NN 1A) (CC and) (NN B)) (-RRB- -RRB-)))) (. .)) )
( (S (PP-LOC (IN In) (NP (DT the) (JJ artificial) (NN exon))) (, ,) (NP-SBJ (DT a) (NN loxP) (ADJP (NN site) (HYPH -) (VBN flanked)) (JJ selectable) (NN marker) (PRN (-LRB- -LRB-) (NP (NN neo)) (-RRB- -RRB-))) (VP (VBZ precedes) (NP (NP (CD two) (VBG coding) (NNS sequences)) (VP (VBN separated) (NP (-NONE- *)) (PP (IN by) (NP-LGS (DT an) (NML (NML (JJ internal) (JJ ribosomal) (NN entry) (NN site)) (-LRB- -LRB-) (NML (NN IRES)))))))) (-RRB- -RRB-) (. .)) )
( (S (S (NP-SBJ (DT The) (JJ upstream) (NN sequence)) (VP (VBZ is) (VP (VBG coding) (PP (IN for) (NP (NN rtTA))) (PP-MNR (IN with) (NP (DT a) (JJ nuclear) (NN localization) (NN signal)))))) (, ,) (CC and) (S (NP-SBJ (DT the) (JJ downstream) (NN sequence)) (VP (VBZ is) (VP (VBG coding) (PP (IN for) (NP (NP (VBN enhanced) (JJ green) (JJ fluorescent) (NN protein)) (-LRB- -LRB-) (NP (NN EGFP))))))) (-RRB- -RRB-) (. .)) )
( (S (NP-SBJ-1 (NP (NN Translation)) (PP (IN of) (NP (DT the) (JJ latter)))) (VP (VBZ is) (VP (VBN ensured) (NP-1 (-NONE- *)) (PP (IN by) (NP-LGS (DT the) (NN IRES) (NN sequence))))) (. .)) )
( (S (PP-TMP (IN Before) (NP (NN Cre) (HYPH -) (NN excision))) (, ,) (S (S (NP-SBJ (NP (DT the) (CD three) (JJ consecutive) (NN polyadenylation) (NNS signals)) (PP (IN of) (NP (DT the) (JJ selectable) (NN marker)))) (VP (VBP terminate) (NP (NN mRNA) (NN synthesis)))) (CC and) (, ,) (S (ADVP (RB therefore)) (, ,) (NP-SBJ-1 (DT the) (JJ downstream) (NN coding) (NNS sequences)) (VP (VBP are) (RB not) (VP (VBN expressed) (NP-1 (-NONE- *)) (PRN (-LRB- -LRB-) (NP (CD 8)) (-RRB- -RRB-)))))) (. .)) )
( (S (PP-TMP (IN After) (NP (NP (ADJP (NN Cre) (HYPH -) (VBN mediated)) (NN deletion)) (PP (IN of) (NP (DT the) (ADJP (NN loxP) (VBN flanked)) (NN sequence))))) (, ,) (ADVP (RB however)) (, ,) (NP-SBJ-1 (NN rtTA) (CC and) (NN EGFP)) (VP (VBP are) (VP (VBN expressed) (NP-1 (-NONE- *)) (PP (IN by) (NP-LGS (DT the) (NN ROSA26) (NN promoter))))) (. .)) )
( (S (NP-SBJ (NP (NN Presence)) (PP (IN of) (NP (NN doxycycline)))) (VP (VBZ results) (PP (IN in) (NP (NP (NP (DT the) (NN formation)) (PP (IN of) (NP (DT an) (JJ active) (JJ transcriptional) (NN activator)))) (CC and) (NP (NP (DT the) (NN activation)) (PP (IN of) (NP (DT the) (NN responder) (NN transgene)))))) (PRN (-LRB- -LRB-) (S-IMP (NP-SBJ (-NONE- *PRO*)) (VP (VB see) (NP (NN Figure) (CD 2)))) (-RRB- -RRB-))) (. .)) )
( (HEADING (NP (NP (NN Assessment)) (PP (IN of) (NP (NN tetracycline) (HYPH -) (NN inducibility))) (ADVP-LOC (FW in) (FW vitro)))) )
( (S (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO To) (VP (VB test) (NP (NP (DT the) (NN inducibility)) (PP (IN of) (NP (DT the) (NN system)))) (ADVP-LOC (FW in) (FW vitro))))) (, ,) (NP-SBJ (PRP we)) (VP (VBD removed) (NP (DT the) (ADJP (NN loxP) (VBN flanked)) (NN sequence)) (PP-MNR (IN by) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG transfecting) (NP (CD 10) (VBN targeted) (NML (NN ES) (NN cell)) (NNS lines)) (PP-MNR (IN with) (NP (NP (NP (DT a) (NN plasmid)) (VP (VBG expressing) (NP (NP (NN Cre) (NN recombinase)) (CONJP (RB as) (RB well) (IN as)) (NP (NN puromycin) (NN acyltransferase))))) (-LRB- -LRB-) (NP (NN pCAGGS) (HYPH -) (NN Cre) (HYPH -) (NN PGK) (HYPH -) (NN Puro)))))))) (-RRB- -RRB-) (. .)) )
( (S (NP-SBJ (PRP We)) (VP (VP (VBD isolated) (NP (JJ stable) (NNS integrants)) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (NN puromycin) (NN selection))))) (CC and) (VP (VBD verified) (SBAR (IN that) (S (NP-SBJ (PRP they)) (VP (VBD displayed) (NP (JJ green) (NN fluorescence)) (SBAR-ADV (IN while) (S (NP-SBJ (DT the) (JJ parental) (NN cell) (NNS lines)) (VP (VBD were) (RB not) (ADJP-PRD (JJ fluorescent)))))))) (PRN (-LRB- -LRB-) (UCP (NP (NN Figure) (NN 1C)) (CC and) (S (NP-SBJ-1 (NNS data)) (RB not) (VP (VBN shown) (NP-1 (-NONE- *))))) (-RRB- -RRB-)))) (. .)) )
( (S (NP-SBJ (EX There)) (VP (VBD was) (NP-PRD (DT no) (NN difference)) (PP (IN among) (NP (DT the) (JJ different) (VBN targeted) (NN cell) (NNS lines)))) (. .)) )
( (S (S (ADVP-TMP (RB Next)) (, ,) (NP-SBJ (PRP we)) (VP (VP (VBD expanded) (NP (NP (DT the) (JJ fluorescent) (ADJP (NN Cre) (HYPH -) (VBN excised)) (NNS subclones)) (PP (IN of) (NP (NP (CD two) (JJ original) (NNS lines)) (-LRB- -LRB-) (NP (NN 1C12) (CC and) (NN 1H6)))))) (-RRB- -RRB-) (CC and) (VP (VBN transfected) (NP (PRP them)) (PP-MNR (IN with) (NP (NP (DT a) (NN vector)) (VP (VBG containing) (NP (NP (DT a) (NN lacZ) (NN transgene)) (VP (VBN driven) (NP (-NONE- *)) (PP (IN by) (NP-LGS (NP (DT a) (ADJP (NN rtTA) (HYPH -) (JJ responsive)) (NN promoter)) (-LRB- -LRB-) (NP (NN tet) (HYPH -) (NN O) (HYPH -) (NN LacZ))))))))))) (-RRB- -RRB-) (. .)) (S (-LRB- -LRB-) (NP-SBJ (PRP We)) (VP (VBD did) (RB not) (VP (VB use) (NP (NP (DT any) (NN selection)) (PP (IN for) (NP (NNS transfectants)))) (PP (IN in) (NP (DT this) (NN experiment))))) (. .) (-RRB- -RRB-))) )
( (S (NP-SBJ (PRP We)) (VP (VBD did) (RB not) (VP (VB observe) (NP (DT any) (NML (NN X) (HYPH -) (NN gal)) (NN activity)) (PP (IN in) (NP (NP (DT the) (NN absence)) (PP (IN of) (NP (DT the) (NN inducer))))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 1D)) (-RRB- -RRB-)))) (. .)) )
( (S (SBAR-TMP (WHADVP-3 (WRB When)) (S (NP-SBJ-1 (DT the) (NN medium)) (VP (VBD was) (VP (VBN supplemented) (NP-1 (-NONE- *)) (PP-MNR (IN with) (NP (NML (NML (CD 100) (NN ng)) (PP (SYM /) (NP (NN ml)))) (NN doxycycline))) (ADVP-TMP-3 (-NONE- *T*)))))) (, ,) (NP-SBJ-2 (NN LacZ) (JJ positive) (NNS cells)) (VP (VBD were) (VP (VBN detected) (NP-2 (-NONE- *)) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 1E)) (-RRB- -RRB-)))) (. .)) )
( (HEADING (NP (NP (JJ Inducible) (NN overexpression)) (PP (IN of) (NP (NN VEGF) (HYPH -) (NN A))) (ADVP-LOC (FW in) (FW vivo)))) )
( (S (NP-SBJ-1 (CD Two) (NML (NN ES) (HYPH -) (NN cell)) (NNS clones)) (VP (VBD were) (VP (VBN used) (NP-1 (-NONE- *)) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB generate) (NP (JJ chimeric) (NNS mice)) (PP-MNR (IN by) (NP (NML (NML (NN ES) (NNS cells)) (PP (SYM ⇔) (NP (NN embryo)))) (NN aggregation)))))))) (. .)) )
( (S (PP (IN In) (NP (DT both) (NNS experiments))) (, ,) (NP-SBJ-1 (NN germline) (NN transmission)) (VP (VBD was) (VP (VBN obtained) (NP-1 (-NONE- *)))) (. .)) )
( (S (NP-SBJ (NP (JJ Heterozygous) (NNS animals)) (PP (IN of) (NP (DT both) (NNS lines)))) (VP (VP (VBD were) (ADJP-PRD (JJ healthy) (, ,) (JJ fertile))) (CC and) (VP (VBD had) (NP (DT a) (JJ normal) (NN lifespan)))) (. .)) )
( (S (NP-SBJ-1 (NP (NNS Heterozygotes)) (PP (IN from) (NP (NP (NP (CD one)) (PP (IN of) (NP (DT the) (NNS lines)))) (-LRB- -LRB-) (NP (NN 1C12)) (-RRB- -RRB-)))) (VP (VBD were) (VP (VBN intercrossed) (NP-1 (-NONE- *)) (, ,) (S-ADV (NP-SBJ (-NONE- *PRO*)) (VP (VBG resulting) (PP (IN in) (NP (NP (NNS litters)) (PP (IN of) (NP (NP (NNS pups)) (PP (IN with) (NP (NP (DT a) (JJ Mendelian) (NN distribution)) (PP (IN of) (NP (DT the) (NN F2) (NNS genotypes))))))))))))) (. .)) )
( (S (NP-SBJ-1 (JJ Homozygous) (JJ transgenic) (NNS animals)) (VP (VP (VBD were) (ADJP-PRD (JJ healthy) (CC and) (JJ fertile))) (CC and) (VP (VBD were) (VP (VBN used) (NP-1 (-NONE- *)) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB maintain) (NP (DT this) (NN line)) (PP (IN in) (NP (DT the) (JJ homozygous) (NN state))))))))) (. .)) )
( (S (NP-SBJ-1 (DT These) (JJ homozygous) (, ,) (ADJP (NN Cre) (HYPH -) (JJ conditional)) (NML (NN ROSA26) (HYPH -) (NN rtTA)) (NNS mice)) (VP (VBD were) (VP (VBN used) (NP-1 (-NONE- *)) (PP (IN in) (NP (JJ consecutive) (NNS experiments))))) (. .)) )
( (S (PP-PRP (IN In) (NP (NN order) (S (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB test) (NP (NP (NP (DT the) (ADJP (FW in) (FW vivo)) (`` ‘) (ADJP (JJ silent) (CC but) (JJ inducible)) ('' ’) (NN nature)) (PP (IN of) (NP (DT the) (JJ conditional) (NML (NN ROSA26) (HYPH -) (NN rtTA) (HYPH -) (NN IRES) (HYPH -) (NN EGFP)) (NN transgene)))) (CC and) (NP (NML (NN rtTA) (NN protein)) (NN activity)))))))) (, ,) (NP-SBJ-2 (NP (JJ male) (NNS mice)) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBD were) (ADJP-PRD (JJ homozygous) (PP (IN for) (NP (DT the) (ADJP (NN Cre) (HYPH -) (JJ conditional)) (NML (NN ROSA26) (HYPH -) (NN rtTA)) (NN allele)))))))) (VP (VBD were) (VP (VBN bred) (NP-2 (-NONE- *)) (PP (IN with) (NP (NP (JJ female) (NNS mice)) (SBAR (WHNP-3 (WDT that)) (S (NP-SBJ-3 (-NONE- *T*)) (VP (VBD were) (ADJP-PRD (RB double) (JJ heterozygous) (PP (IN for) (NP (NP (DT a) (NML (NN tet) (HYPH -) (NN O) (HYPH -) (NN VEGF) (HYPH -) (NN A) (HYPH -) (CD 164)) (NN responder) (NN transgene) (PRN (-LRB- -LRB-) (NP (CD 21)) (-RRB- -RRB-))) (CC and) (NP (CC either) (NP (NP (DT the) (JJ ubiquitous) (NML (NN Cre) (HYPH -) (NN deletor)) (NN line)) (-LRB- -LRB-) (NP (NN pCAGGS) (HYPH -) (NN CreTg) (HYPH /) (SYM +)) (-RRB- -RRB-) (PRN (-LRB- -LRB-) (NP (CD 5)) (-RRB- -RRB-))) (CC or) (NP (NP (DT a) (ADJP (NP (JJ nervous) (NN system)) (JJ specific) (PRN (-LRB- -LRB-) (NP (NN Nestin) (HYPH -) (NN CreTg) (HYPH /) (SYM +)) (-RRB- -RRB-)) (PRN (-LRB- -LRB-) (NP (CD 22)) (-RRB- -RRB-))) (NML-4 (-NONE- *RNR*))) (CC or) (NP (DT a) (ADJP (NN podocyte) (JJ specific) (PRN (-LRB- -LRB-) (NP (NN Podocin) (HYPH -) (NN CreTg) (HYPH /) (SYM +)) (-RRB- -RRB-))) (NML-4 (-NONE- *RNR*))) (NML-4 (NN Cre) (NN line)))))))))))))) (. .)) )
( (S (NP-SBJ (NN Figure) (CD 2)) (VP (VBZ describes) (SBAR (WHADVP-2 (WRB how)) (S (NP-SBJ-1 (DT the) (CD three) (NNS transgenes)) (VP (VBP work) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (TO to) (VP (VB unite) (NP (DT the) (NML (NML (NN Cre) (HYPH /) (NN loxP)) (CC and) (NML (NN tetracycline))) (JJ inducible) (NNS systems))))) (ADVP-MNR-2 (-NONE- *T*)))))) (. .)) )
( (S (SBAR-PRP (IN Since) (S (NP-SBJ (DT the) (NML (NN pCAGGS) (HYPH -) (NN Cre)) (NN transgene)) (VP (VBZ expresses) (NP (NN Cre)) (PP-LOC (IN in) (NP (NP (PDT all) (DT the) (NNS cells)) (PP (IN of) (NP (DT the) (JJ early) (NN embryo)))))))) (, ,) (NP-SBJ (PRP it)) (VP (VBZ activates) (NP (NP (DT an) (JJ overall) (NN rtTA) (NML-2 (-NONE- *RNR*))) (CC and) (NP (NN EGFP) (NML-2 (-NONE- *RNR*))) (NML-2 (NN expression))) (SBAR-ADV (IN as) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (VBN shown) (NP-1 (-NONE- *)) (PP (IN for) (NP (DT a) (NML (NN E9.5) (NN day)) (NN embryo))) (PP (IN in) (NP (NN Figure) (NML (NN 3B) (CC and) (NN E)))))))) (. .)) )
( (S (PP (IN On) (NP (DT the) (JJ other) (NN hand))) (, ,) (NP-SBJ (NP (VBG breeding)) (PP (IN with) (NP (DT the) (NML (NML (NN Nestin) (HYPH -) (NN Cre)) (CC or) (NML (NN Podocin) (HYPH -) (NN Cre))) (NN line)))) (VP (VBD resulted) (PP (IN in) (NP (NP (NNS embryos) (HYPH /) (NNS animals)) (PP (IN with) (NP (NP (JJ neuronal) (NN lineage)) (CC or) (NP (NP (ADJP (NN glomerulus) (HYPH -) (JJ specific)) (NN expression)) (PP (IN of) (NP (NN rtTA) (CC and) (NN EGFP)))))))) (, ,) (ADVP (RB respectively)) (, ,) (SBAR-ADV (IN as) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (VP (VBN shown) (NP-1 (-NONE- *)) (PP=4 (IN in) (NP (NN Figure) (NN 3G))) (PP=3 (IN for) (NP (DT a) (NML (NN E10.5) (NN day)) (NN embryo))) (PP=2 (IN for) (NP (NN Nestin) (HYPH -) (NN Cre)))) (CC and) (VP (PP=4 (IN in) (NP (NN Figure) (NN 3J))) (PP=3 (IN for) (NP (DT a) (JJ newborn) (NN glomerulus))) (PP=2 (IN for) (NP (NN Podocin) (HYPH -) (NN Cre)))))))) (. .)) )
( (S (PP (IN In) (NP (NP (DT the) (NN absence)) (PP (IN of) (NP (NP (ADJP (NN Cre) (HYPH -) (VBN mediated)) (NN excision)) (PP (IN of) (NP (DT the) (NN loxP) (HYPH -) (VBN flanked))))))) (NP-SBJ (NML (NN PGK) (HYPH -) (NN neo) (HYPH -) (NN pA)) (NN sequence)) (VP (VBZ blocks) (NP (NML (NN rtTA) (CC and) (NN EGFP)) (NN expression))) (. .)) )
( (S (NP-SBJ (PRP We)) (VP (VBD made) (NP (NN use)) (PP (IN of) (NP (NP (DT the) (JJ tight) (NN dosage) (NN sensitivity)) (PP (IN of) (NP (DT the) (JJ early) (VBG developing) (NN embryo))) (PP (IN to) (NP (NP (ADJP (ADJP (VBN increased) (PRN (-LRB- -LRB-) (NP (CD 9) (, ,) (CD 23)) (-RRB- -RRB-))) (CC or) (ADJP (VBN decreased))) (NNS levels)) (PP (IN of) (NP (NN VEGF) (HYPH -) (NN A) (PRN (-LRB- -LRB-) (NP (NP (CD 20)) (, ,) (NP (NP (CD 23)) (PP (SYM –) (NP (CD 26))))) (-RRB- -RRB-)))))))) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB demonstrate) (NP (NP (DT the) (JJ correct) (NN activation)) (PP (IN of) (NP (PRP$ our) (JJ inducible) (NN system)))))))) (. .)) )
( (S (PP (IN In) (NP (NP (DT the) (NN absence)) (PP (IN of) (NP (NP (DT the) (NN rtTA) (HYPH -) (NN inducer)) (NP (NN doxycycline)))))) (, ,) (NP-SBJ (ADJP (JJ triple) (JJ transgenic)) (NML (NML (NML (NN pCAGGS) (HYPH -) (NN CreTg)) (HYPH /) (NML (SYM +))) (, ,) (NML (NML (NN ROSA26) (HYPH -) (NN rtTA) (HYPH -) (NN IRES) (HYPH -) (NN EGFPTg)) (HYPH /) (NML (SYM +))) (, ,) (NML (NML (NN tet) (HYPH -) (NN O) (HYPH -) (NN VEGF) (HYPH -) (NN A) (HYPH -) (NN 164Tg)) (HYPH /) (NML (SYM +)))) (NNS embryos) (PRN (-LRB- -LRB-) (NN Figure) (NML (NN 3A) (CC and) (NN B)) (-RRB- -RRB-))) (VP (VP (VBP develop) (ADVP (RB normally))) (CC and) (VP (VBP show) (NP (DT no) (NN phenotype)))) (. .)) )
( (S (ADVP (RB However)) (, ,) (PP (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NP (NN doxycycline)) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBD was) (VP (VBN administered) (NP-1 (-NONE- *)) (PP (IN to) (NP (JJ pregnant) (NNS females))) (S-ADV (NP-SBJ (-NONE- *PRO*)) (VP (VBG starting) (NP-TMP (NP (CD one) (NN day)) (PP (IN after) (NP (NN mating))) (PRN (-LRB- -LRB-) (NP (NN E1.5)) (-RRB- -RRB-))))))))))))) (, ,) (NP-SBJ (NP (DT all)) (PP (IN of) (NP (DT these) (ADJP (JJ triple) (JJ transgenic)) (NNS embryos)))) (VP (VBD showed) (NP (NN lethality)) (PRN (-LRB- -LRB-) (UCP (NP (NN Figure) (NML (NN 3D) (CC and) (NN E))) (CC and) (S-IMP (NP-SBJ (-NONE- *PRO*)) (VP (VB see) (NP (NN Table) (CD 1))))) (-RRB- -RRB-)) (PP-TMP (IN at) (NP (NN E9.5)))) (. .)) )
( (S (S (NP-SBJ (NP (DT The) (NNS phenotypes)) (PP (IN of) (NP (DT these) (NN mutant) (NNS embryos)))) (VP (VBD were) (ADJP-PRD (RB quite) (JJ severe)) (SBAR-ADV (IN with) (S (NP-SBJ (DT no) (JJ primitive) (NML (NML (JJ red) (NN blood) (NNS cells)) (-LRB- -LRB-) (NML (NNS RBCs)))) (-RRB- -RRB-) (VP (VBN observed) (NP (-NONE- *)) (PP-LOC (IN in) (NP (DT the) (VBG developing) (NN yolk) (NN sac))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 3D)) (-RRB- -RRB-))))))) (CC and) (S (NP-SBJ-1 (NNS embryos)) (VP (VBD were) (VP (VBN blocked) (NP-1 (-NONE- *)) (PP-TMP (IN in) (NP (NN development)))))) (. .)) )
( (S (PP (IN Unlike) (NP (NP (DT the) (JJ original) (JJ homozygous) (NML (NN VEGF) (HYPH -) (NN A)) (NNS mutants)) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBD showed) (NP (NP (DT a) (JJ severe) (NN reduction)) (PP (IN of) (NP (NML (NN blood) (NN island)) (NN development)))) (PP-LOC (IN in) (NP (DT the) (NN yolk) (NN sac))) (PRN (-LRB- -LRB-) (NP (CD 24) (, ,) (CD 25)) (-RRB- -RRB-))))))) (, ,) (NP-SBJ (NP (JJ ubiquitous) (NML (NN VEGF) (HYPH -) (NN A) (HYPH -) (CD 164)) (NN expression)) (PP (IN in) (NP (DT this) (ADJP (JJ triple) (JJ transgenic)) (JJ inducible) (NN system)))) (VP (VBD led) (PP (IN to) (NP (NP (NP (JJ enlarged) (NN blood) (NNS islands)) (PP-LOC (IN in) (NP (DT the) (NN yolk) (NN sac)))) (SBAR (WHNP-2 (WDT that)) (S (NP-SBJ-2 (-NONE- *T*)) (VP (VBD were) (VP (VBN filled) (NP-2 (-NONE- *)) (PP-MNR (IN with) (NP (VBN nucleated) (NN erythroblast) (NNS progenitors))))))))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 3F)) (-RRB- -RRB-))) (. .)) )
( (S (S (NP-SBJ (NP (DT The) (JJ normal) (NN blood) (NNS islands)) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBD developed) (PP-LOC (IN in) (NP (DT the) (JJ non-induced) (NNS embryos))))))) (VP (VBD showed) (NP (NP (ADJP (RB clearly) (VBN defined)) (ADJP (JJ endodermal) (CC and) (JJ mesodermal)) (NNS layers)) (VP (`` ‘) (VBG sandwiching) ('' ’) (NP (DT the) (VBG developing) (NN blood) (NNS islands)))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 3C)) (-RRB- -RRB-)))) (: ;) (S (ADVP (RB however)) (, ,) (PP-LOC (IN in) (NP (DT the) (ADJP (NN doxycycline) (HYPH -) (VBN induced)) (NNS embryos))) (, ,) (NP-SBJ (JJ aberrant) (NN blood) (NNS islands)) (VP (VBD formed) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 3F)) (-RRB- -RRB-)))) (. .)) )
( (S (NP-SBJ (PDT All) (DT the) (CD 10) (ADJP (JJ triple) (JJ transgenic)) (NNS embryos)) (VP (VBD showed) (NP (NP (DT the) (JJ same) (NN mutant) (NN phenotype)) (VP (VBN described) (NP (-NONE- *)) (ADVP (RB above)))) (PP-TMP (IN upon) (NP (NP (NN doxycycline) (NN administration)) (PP (IN to) (NP (PRP$ their) (NNS mothers))))) (PRN (-LRB- -LRB-) (NP (NN Table) (CD 1)) (-RRB- -RRB-))) (. .)) )
( (S (PP-TPC-2 (IN Out) (PP (IN of) (NP (NP (DT the) (CD 22) (VBG remaining) (NNS littermates)) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBD were) (ADJP-PRD (ADVP (CC either) (RB single) (CC or) (RB double)) (JJ transgenic) (PP (IN for) (NP (DT the) (CD three) (NNS transgenes)))))))))) (, ,) (NP-SBJ-3 (NP (CD 20)) (PP-2 (-NONE- *T*))) (VP (VBD appeared) (S (NP-SBJ-3 (-NONE- *)) (ADJP-PRD (RB totally) (JJ normal)))) (. .)) )
( (S (NP-SBJ (CD Two) (NML (NML (NN rtTA) (HYPH -) (NN IRES) (HYPH -) (NN EGFPTg)) (HYPH /) (NML (SYM +))) (, ,) (NML (NML (NN tet) (HYPH -) (NN O) (HYPH -) (NN VEGF) (HYPH -) (NN A) (HYPH -) (JJ 164Tg)) (HYPH /) (NML (SYM +))) (, ,) (ADJP (NN Cre) (HYPH -) (JJ negative)) (NNS embryos) (PRN (-LRB- -LRB-) (SBAR (IN as) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (VBN judged) (NP-1 (-NONE- *)) (PP-MNR (IN by) (NP (NP (NNP Southern) (NN hybridization)) (CC and) (NP (NN PCR))))))) (, ,) (S (NP-SBJ-2 (NNS data)) (RB not) (VP (VBN shown) (NP-2 (-NONE- *)))) (-RRB- -RRB-))) (, ,) (ADVP (RB however)) (, ,) (VP (VBD were) (ADVP (RB also)) (NP-PRD (NN EGFP) (NNS expressers)) (S-ADV (NP-SBJ (-NONE- *PRO*)) (VP (VBG indicating) (SBAR (IN that) (S (NP-SBJ (NML (NN rtTA) (NN expression)) (NN activation) (PRN (-LRB- -LRB-) (NP (NN Cre) (HYPH -) (NN excision)) (-RRB- -RRB-))) (VP (VBD occurred) (PP-MNR (IN by) (NP (ADJP (RB maternally) (VBN produced)) (NN Cre) (NN protein))))))))) (. .)) )
( (S (NP-SBJ (DT This) (VBN known) (NN phenomenon)) (VP (VBZ is) (NP-PRD (NP (DT a) (NN consequence)) (PP (IN of) (NP (NP (JJ high) (HYPH -) (NN Cre) (NML (NN production) (CC and) (NN accumulation))) (PP-TMP (IN during) (NP (NN oogenesis)))))) (PRN (-LRB- -LRB-) (NP (CD 27)) (-RRB- -RRB-))) (. .)) )
( (S (NP-SBJ (DT The) (NML (NML (NML (JJ ubiquitous) (JJ systemic) (NML (NN administration) (CC or) (NN induction))) (PP (IN of) (NP (DT the) (NML (NN VEGF) (HYPH -) (NN A) (HYPH -) (CD 164)) (NN protein)))) (, ,) (CC or) (NML (NML (NN injection)) (PP (IN of) (NP (NP (NN tumor) (NNS cells)) (VP (VBG expressing) (NP (NP (JJ high) (NNS levels)) (PP (IN of) (NP (NML (NN VEGF) (HYPH -) (NN A) (HYPH -) (CD 164)) (NN protein))))))) (PP (IN into) (NP (JJ adult) (NNS mice)))))) (, ,) (VP (VBZ results) (PP (IN in) (NP (NP (JJ severe) (NN edema) (PRN (-LRB- -LRB-) (NP (NP (CD 28)) (PP (SYM –) (NP (CD 30)))) (-RRB- -RRB-))) (, ,) (NP (NP (NNS defects)) (PP (IN in) (NP (NML (NN immune) (NN cell)) (NN function))) (PP (VBG including) (NP (NP (NP (NN destruction)) (PP (IN of) (NP (DT the) (NN thymus))) (PRN (-LRB- -LRB-) (NP (NP (CD 31)) (PP (SYM –) (NP (CD 33)))) (-RRB- -RRB-))) (CC and) (NP (NP (NN liver) (NNS pathologies)) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (ADVP (RB closely)) (VP (VBP resemble) (NP (NP (DT the) (JJ human) (NN syndrome)) (VP (VBN known) (NP (-NONE- *)) (PP (IN as) (NP (NP (NN peliosis) (NN hepatis)) (SBAR (WHNP-2 (WDT that)) (S (NP-SBJ-2 (-NONE- *T*)) (VP (VBZ has) (VP (VBN been) (VP (VBN described) (NP-2 (-NONE- *)) (PP (IN in) (NP (NP (NN association)) (PP (PP (IN with) (NP (NP (NML (NNP Bartonella) (NNP henselae)) (NN infection)) (, ,) (NP (NML (JJ long) (HYPH -) (NN term)) (NML (JJ high) (HYPH -) (NN dose)) (NN androgen) (NN therapy)))) (, ,) (CC or) (PP (ADVP-TMP (RB rarely)) (IN with) (NP (JJ advanced) (NNS cancers)))))))))))))))))) (PRN (-LRB- -LRB-) (NP (CD 34)) (-RRB- -RRB-))))))))) (. .)) )
( (S (PP-PRP (IN In) (NP (NN order) (S (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB determine) (SBAR (IN if) (S (NP-SBJ (ADJP (NN doxycycline) (HYPH -) (VBN induced)) (JJ overall) (NML (NN VEGF) (HYPH -) (NN A) (HYPH -) (CD 164)) (NN expression)) (VP (MD could) (VP (VB mimic) (NP (NP (DT some) (CC or) (DT all)) (PP (IN of) (NP (DT these) (ADJP (RB previously) (VBN described)) (NNS phenotypes))))))))))))) (, ,) (S (S (NP-SBJ-1 (ADJP (JJ triple) (JJ transgenic)) (NML (NML (NML (NN pCAGGS) (HYPH -) (NN CreTg)) (HYPH /) (NML (SYM +))) (, ,) (NML (NML (NN ROSA26) (HYPH -) (NN rtTA) (HYPH -) (NN IRES) (HYPH -) (NN EGFPTg)) (HYPH /) (NML (SYM +))) (, ,) (NML (NML (NN tet) (HYPH -) (NN O) (HYPH -) (NN VEGF) (HYPH -) (NN A) (HYPH -) (NN 164Tg)) (HYPH /) (NML (SYM +)))) (NNS mice)) (VP (VBD were) (VP (VBN allowed) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB reach) (NP (NN adulthood)))))))) (CC and) (S (NP-SBJ-2 (NP (DT a) (NN regimen)) (PP (IN of) (NP (NN doxycycline) (NN administration)))) (VP (VBD was) (VP (VBN followed) (NP-2 (-NONE- *)) (PRN (-LRB- -LRB-) (NP (NN Table) (CD 1)) (-RRB- -RRB-)))))) (. .)) )
( (S (NP-SBJ-2 (DT These) (ADJP (JJ triple) (JJ transgenic)) (NNS mice)) (VP (VP (VBD were) (VP (VBN born) (NP-2 (-NONE- *)) (PP (IN in) (NP (DT a) (JJ normal) (JJ Mendelian) (NN frequency))))) (CC and) (VP (VBD showed) (NP (NP (DT no) (NN sign)) (PP (IN of) (NP (DT any) (JJ phenotypic) (NNS abnormalities)))) (PRN (-LRB- -LRB-) (UCP (NP (NN Figure) (NML (NML (NML (NN 4A)) (PP (SYM –) (NP (NN C)))) (CC and) (NML (NML (NN G)) (PP (SYM –) (NP (NN I)))))) (, ,) (CC and) (S (NP-SBJ-1 (NNS data)) (RB not) (VP (VBN shown) (NP-1 (-NONE- *))))) (-RRB- -RRB-)))) (. .)) )
( (S (PP-TMP (IN Upon) (NP (NP (NN administration)) (PP (IN of) (NP (NN doxycycline))) (PP (IN in) (NP (DT the) (NN drinking) (NN water))) (PP (IN to) (NP (ADJP (NP (QP (CD 3) (SYM –) (CD 4)) (NN month)) (JJ old)) (NML (NML (NML (NN pCAGGS) (HYPH -) (NN CreTg)) (HYPH /) (NML (SYM +))) (, ,) (NML (NML (NN ROSA26) (HYPH -) (NN rtTA) (HYPH -) (NN IRES) (HYPH -) (NN EGFPTg)) (HYPH /) (NML (SYM +))) (, ,) (NML (NML (NN tet) (HYPH -) (NN O) (HYPH -) (NN VEGF) (HYPH -) (NN A) (HYPH -) (NN 164Tg)) (HYPH /) (NML (SYM +)))) (NNS mice))))) (, ,) (NP-SBJ (JJ several) (NNS phenotypes)) (VP (VBD became) (ADJP-PRD (JJ apparent)) (ADVP-TMP (RB already)) (PP-TMP (IN after) (NP (NP (CD 2) (NNS days)) (PP (IN of) (NP (NN treatment)))))) (. .)) )
( (S (NP-SBJ (DT The) (NNS mice)) (VP (VBD showed) (NP (NP (NNS signs)) (PP (IN of) (NP (NP (NN edema) (CC and) (NN erythema)) (PP (IN of) (NP (DT the) (NML (NN face) (, ,) (NNS ears) (CC and) (NNS feet))))))) (PRN (-LRB- -LRB-) (S (NP-SBJ-1 (NNS data)) (RB not) (VP (VBN shown) (NP-1 (-NONE- *)))) (-RRB- -RRB-))) (. .)) )
( (S (PP-TMP (IN By) (NP (NP (CD 5) (NNS days)) (PP (IN of) (NP (NN doxycycline) (NN administration))))) (, ,) (S (S (NP-SBJ (QP (CD three) (IN of) (DT the) (CD eight)) (ADJP (JJ triple) (JJ transgenic)) (NNS mice)) (VP (VBD had) (VP (VBN died)))) (CC and) (S (NP-SBJ (CD three)) (VP (VBD were) (ADJP-PRD (ADJP (RB so) (ADJP (JJ moribund)) (CC and) (ADJP (JJ sickly) (PP (IN in) (NP (NN appearance))))) (SBAR (IN that) (S (S (NP-SBJ-1 (PRP they)) (VP (VBD had) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB be) (VP (VBN euthanized) (NP-1 (-NONE- *)))))))) (CC and) (S (NP-SBJ-2 (PRP$ their) (NNS organs)) (VP (VBD were) (VP (VBN harvested) (NP-2 (-NONE- *)) (PP-PRP (IN for) (NP (JJ further) (JJ histological) (NN analysis)))))))))))) (. .)) )
( (S (NP-SBJ-1 (CD Two) (NNS mice)) (VP (VP (VBD seemed) (S (NP-SBJ-1 (-NONE- *)) (ADJP-PRD (RBR more) (JJ resistant) (PP (IN to) (NP (DT the) (NN doxycycline) (NN administration)))))) (CC and) (VP (VBD were) (VP (VBN given) (NP-1 (-NONE- *)) (NP (DT the) (NN drug)) (PP-TMP (IN for) (NP (NP (DT an) (JJ additional) (CD 4) (NNS days)) (SBAR (WHPP-3 (IN at) (WHNP (WDT which) (NN time))) (S (NP-SBJ-2 (PRP they)) (ADVP (RB too)) (VP (VP (VBD became) (ADJP-PRD (JJ moribund))) (CC and) (VP (VBD were) (ADVP (RB as) (RB well)) (VP (VBN sacrificed) (NP-2 (-NONE- *)))) (PP-TMP-3 (-NONE- *T*)))))))))) (. .)) )
( (S (PP-TPC-1 (IN Of) (NP (DT the) (CD 10) (ADJP (ADJP (JJ single) (CC and) (JJ double)) (JJ transgenic)) (NNS littermates))) (, ,) (NP-SBJ (NP (CD 9)) (PP-1 (-NONE- *T*))) (VP (VP (VBD were) (ADJP-PRD (RB completely) (JJ normal))) (CC and) (VP (VBD showed) (NP (NP (DT no) (JJ adverse) (NN side) (NNS affects)) (PP (IN to) (NP (DT the) (NN doxycycline) (NN administration)))))) (. .)) )
( (S (S-ADV (NP-SBJ (-NONE- *PRO*)) (ADJP-PRD (NP (JJ Similar)) (PP (IN to) (SBAR-NOM (WHNP-1 (WP what)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBD was) (VP (VBN observed) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (DT the) (NN E9.5) (NNS embryos)))))))))) (, ,) (NP-SBJ (CD one) (NML (NML (NML (NN rtTA) (HYPH -) (NN IRES) (HYPH -) (NN EGFPTg)) (HYPH /) (NML (SYM +))) (, ,) (NML (NML (NN tet) (HYPH -) (NN O) (HYPH -) (NN VEGF) (HYPH -) (NN A) (HYPH -) (NN 164Tg)) (HYPH /) (NML (SYM +)))) (, ,) (ADJP (NN Cre) (HYPH -) (JJ negative)) (JJ adult) (NN mouse)) (VP (VBD died) (PP-TMP (IN during) (NP (NN doxycycline) (NN administration)))) (. .)) )
( (S (NP-SBJ (DT This) (NN mouse)) (, ,) (ADVP (RB however)) (, ,) (VP (VBD was) (ADJP-PRD (NN EGFP) (JJ positive)) (, ,) (S-ADV (NP-SBJ (-NONE- *PRO*)) (VP (VBG indicating) (NP (NP (DT the) (NML (NN rtTA) (NN expression)) (NN activation)) (PP (IN by) (NP (JJ zygotic) (-LRB- -LRB-) (JJ maternal) (-RRB- -RRB-) (NN Cre) (NN protein)))) (PRN (-LRB- -LRB-) (NP (CD 27)) (-RRB- -RRB-))))) (. .)) )
( (S (PP-TMP (IN Upon) (NP (NN autopsy))) (, ,) (NP-SBJ (NP (DT the) (ADJP (RBS most) (JJ obvious)) (JJ gross) (NNS phenotypes)) (VP (VBN observed) (NP (-NONE- *)))) (VP (VBD were) (NP-PRD (NP (NP (DT an) (VBN extended) (ADJP (NN blood) (VBN filled)) (NN liver)) (CC and) (NP (NP (DT a) (JJ dramatic) (NN decrease)) (PP (IN in) (NP (NP (DT the) (NN size)) (PP (IN of) (NP (DT the) (NN thymus))))))) (PP (ADVP (RB together)) (IN with) (NP (NP (NP (JJ enlarged) (NN lymph) (NNS nodes)) (CC and) (NP (NP (NNS signs)) (PP (IN of) (NP (NP (NP (NN hyper) (HYPH -) (NN vascularity)) (HYPH /) (NP (NN permeability))) (CC and) (NP (NN edema)))) (PP-LOC (IN in) (NP (JJ several) (JJ other) (NN organ) (NNS systems))))) (CONJP (RB as) (RB well) (IN as)) (NP (NP (NN blood)) (PP-LOC (IN in) (NP (DT the) (NN intestine))))))) (PRN (-LRB- -LRB-) (S (NP-SBJ-1 (NNS data)) (RB not) (VP (VBN shown) (NP-1 (-NONE- *)))) (-RRB- -RRB-))) (. .)) )
( (S (NP-SBJ (NP (JJ Histological) (NN analysis)) (PP (IN of) (NP (NP (DT the) (NN liver)) (PP (IN of) (NP (JJ uninduced) (NML (NML (NML (NN pCAGGS) (HYPH -) (NN CreTg)) (HYPH /) (NML (SYM +))) (, ,) (NML (NML (NN ROSA26) (HYPH -) (NN rtTA) (HYPH -) (NN IRES) (HYPH -) (NN EGFPTg)) (HYPH /) (NML (SYM +))) (, ,) (NML (NML (NN tet) (HYPH -) (NN O) (HYPH -) (NN VEGF) (HYPH -) (NN A) (HYPH -) (NN 164Tg)) (HYPH /) (NML (SYM +)))) (JJ adult) (NNS mice) (PRN (-LRB- -LRB-) (NP (NN control)) (-RRB- -RRB-))))))) (VP (VBD revealed) (NP (JJ normal) (JJ hepatic) (NN architecture)) (PRN (-LRB- -LRB-) (NP (NN Figure) (NML (NML (NN 4A)) (PP (SYM –) (NP (NN C))))) (-RRB- -RRB-))) (. .)) )
( (S (NP-SBJ (ADJP (NN Doxycycline) (HYPH -) (VBN treated)) (NN mutant) (NML (NML (NML (NN pCAGGS) (HYPH -) (NN CreTg)) (HYPH /) (NML (SYM +))) (, ,) (NML (NML (NN ROSA26) (HYPH -) (NN rtTA) (HYPH -) (NN IRES) (HYPH -) (NN EGFPTg)) (HYPH /) (NML (SYM +))) (, ,) (NML (NML (NN tet) (HYPH -) (NN O) (HYPH -) (NN VEGF) (HYPH -) (NN A) (HYPH -) (NN 164Tg)) (HYPH /) (NML (SYM +)))) (JJ adult) (NNS livers)) (VP (VBD showed) (NP (NP (DT a) (ADJP (ADJP (JJ dramatic)) (`` ‘) (ADJP (NN peliosis) (HYPH -) (JJ like)) ('' ’)) (NN phenotype) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 4D)) (-RRB- -RRB-))) (CC and) (NP (NP (NNS signs)) (PP (IN of) (NP (NP (NN blood)) (VP (VBG pooling) (PP-LOC (IN in) (NP (NP (JJ large) (NNS areas)) (PP (IN of) (NP (DT the) (NN liver)))))))))) (PRN (-LRB- -LRB-) (NP (NP (NNS arrows)) (PP (IN in) (NP (NN Figure) (NN 4E)))) (-RRB- -RRB-))) (. .)) )
( (S (NP-SBJ-1 (DT This) (NN liver) (NN peliosis) (NN phenotype)) (VP (VBZ is) (VP (VBN characterized) (NP-1 (-NONE- *)) (PP (IN by) (NP-LGS (NP (NP (JJ enlarged) (JJ hepatic) (NNS sinusoids)) (CC and) (NP (NP (DT a) (JJ total) (NN disruption)) (PP (IN of) (NP (DT the) (JJ normal) (NN liver) (NN architecture)))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NML (NML (NN 4D)) (PP (SYM –) (NP (NN F))))) (-RRB- -RRB-))) (CONJP (RB as) (RB well) (IN as)) (NP (NP (JJ detached) (JJ sinusoidal) (JJ endothelial) (NNS cells)) (SBAR (WHNP-2 (WDT that)) (S (NP-SBJ-2 (-NONE- *T*)) (VP (VBP are) (VP (`` ‘) (VBG sloughing) (HYPH -) (PRT (RP off)) ('' ’) (PP-DIR (IN into) (NP (DT the) (JJ sinusoidal) (NN space))))))) (PRN (-LRB- -LRB-) (NP (NP (NN arrow)) (PP (IN in) (NP (NN Figure) (NN 4F)))) (-RRB- -RRB-))))))) (. .)) )
( (S (NP-SBJ (NP (DT The) (NN liver) (NN pathology)) (VP (VBN described) (NP (-NONE- *)) (ADVP (RB here)))) (VP (VBZ resembles) (NP (NP (DT the) (NN liver) (ADJP (NN peliosis) (HYPH -) (JJ like)) (NN pathology)) (VP (ADVP-TMP (RB recently)) (VBN described) (NP (-NONE- *)) (PP-LOC (IN in) (NP (NP (NNS mice)) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBD had) (VP (VBN been) (VP (VBN engrafted) (NP-1 (-NONE- *)) (PP-MNR (IN with) (NP (NP (NN tumor) (NNS cells)) (VP (VBG expressing) (NP (NP (JJ high) (NNS levels)) (PP (IN of) (NP (JJ systemic) (NML (NN VEGF) (HYPH -) (NN A) (HYPH -) (CD 164)) (NN protein)))))))))))))))) (PRN (-LRB- -LRB-) (NP (CD 34)) (-RRB- -RRB-))) (. .)) )
( (S (PP (IN In) (NP (NN addition))) (, ,) (NP-SBJ (NP (NNP LeCouter)) (ADVP-ETC (FW et) (FW al.)) (PRN (-LRB- -LRB-) (NP (CD 35)) (-RRB- -RRB-))) (VP (VBP have) (VP (VBN observed) (NP (NP (ADJP (JJ similar) (PRN (-LRB- -LRB-) (SBAR (IN although) (FRAG (ADJP (RBR less) (JJ severe)))) (-RRB- -RRB-))) (NML (NN liver) (NN enlargement)) (NNS phenotypes)) (CC and) (NP (NP (NNS effects)) (PP (IN on) (NP (NP (DT the) (JJ sinusoidal) (NN endothelium)) (PP (IN of) (NP (DT the) (NN liver))))))) (PP-MNR (IN with) (NP (NP (JJ systemic) (NN administration)) (PP (IN of) (NP (JJ recombinant) (NML (NN VEGF) (HYPH -) (NN A)) (NN protein))))))) (. .)) )
( (S (NP-SBJ-1 (NP (PRP It)) (SBAR-2 (-NONE- *EXP*))) (VP (VBD was) (ADVP (RB also)) (VP (VBN demonstrated) (NP-1 (-NONE- *)) (SBAR-2 (IN that) (S (NP-SBJ-3 (NP (NN VEGF) (HYPH -) (NN A)) (PP (IN at) (NP (JJR lower) (NNS doses)))) (VP (VP (MD can) (VP (VB act) (PP (IN on) (NP (DT the) (JJ sinusoidal) (NN vasculature))) (-LRB- -LRB-) (PP-MNR (IN via) (NP (NN Flt1))) (-RRB- -RRB-) (S-PRP (NP-SBJ-3 (-NONE- *PRO*)) (VP (TO to) (VP (VB influence) (NP (NP (NN secretion)) (PP (IN of) (NP (NP (NN hepatocyte) (NN growth) (NN factor)) (-LRB- -LRB-) (NP (NN HGF)))))))))) (-RRB- -RRB-) (CC and) (VP (MD may) (VP (VB have) (NP (NP (DT a) (JJ beneficial) (JJ protective) (NN effect)) (PP (IN on) (NP (NNS hepatocytes)))) (PP-TMP (IN under) (NP (NP (NNS times)) (PP (IN of) (NP (JJ cytotoxic) (NN stress)))))))))) (PRN (-LRB- -LRB-) (NP (CD 35)) (-RRB- -RRB-)))) (. .)) )
( (S (NP-SBJ (NP (PRP$ Our) (NML (NN VEGF) (HYPH -) (NN A)) (JJ inducible) (NN system)) (PP (IN with) (NP (NP (ADJP (NN liver) (HYPH -) (JJ specific)) (NN Cre) (NNS lines)) (PP (JJ such) (IN as) (NP (DT the) (NML (NN albumin) (HYPH -) (NN Cre)) (NN line))))) (PRN (-LRB- -LRB-) (NP (CD 36)) (-RRB- -RRB-))) (VP (VP (MD will) (VP (VB be) (ADJP-PRD (JJ useful) (PP (IN in) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG determining) (NP (NP (NP (DT the) (JJ optimal) (NNS dosages)) (PP (IN of) (NP (NN VEGF) (HYPH -) (NN A)))) (VP (VBN required) (NP (-NONE- *)) (PP-PRP (IN for) (NP (NP (PRP$ its) (JJ beneficial) (NN action)) (PP (IN on) (NP (DT the) (NN liver))))) (PP-TMP (IN under) (NP (NP (NNS times)) (PP (IN of) (NP (JJ cytotoxic) (NN stress))))))))))))) (CC and) (VP (MD may) (PP (IN at) (NP (JJR higher) (NN induction) (NNS levels))) (VP (VB be) (NP-PRD (NP (DT a) (JJ useful) (NN model) (NN system)) (SBAR (WHNP-1 (-NONE- *0*)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (TO to) (VP (VB unravel) (NP (NP (DT the) (JJ molecular) (NNS mechanisms)) (PP (IN behind) (NP (NP (NP (NN VEGF) (HYPH -) (NN A) (POS 's)) (JJ harmful) (NNS effects)) (PP (IN on) (NP (DT the) (NN liver)))))))))))))) (. .)) )
( (S (NP-SBJ (NP (DT The) (NN thymus)) (PP (IN of) (NP (JJ non-induced) (NML (NML (NML (NN pCAGGS) (HYPH -) (NN CreTg)) (HYPH /) (NML (SYM +))) (, ,) (NML (NML (NN ROSA26) (HYPH -) (NN rtTA) (HYPH -) (NN IRES) (HYPH -) (NN EGFPTg)) (HYPH /) (NML (SYM +))) (, ,) (NML (NML (NN tet) (HYPH -) (NN O) (HYPH -) (NN VEGF) (HYPH -) (NN A) (HYPH -) (NN 164Tg)) (HYPH /) (NML (SYM +)))) (JJ adult) (NNS mice) (PRN (-LRB- -LRB-) (NP (NN control)) (-RRB- -RRB-))))) (VP (VBD displayed) (NP (NP (NP (DT a) (JJ normal) (JJ thymic) (NN architecture)) (PP (IN with) (NP (NP (DT a) (ADJP (RB well) (HYPH -) (VBN defined)) (JJ cortical) (NN layer)) (ADJP (JJ rich) (PP (IN in) (NP (JJ basophilic) (NNS thymocytes))))))) (CC and) (NP (DT a) (JJ normal) (ADJP (NN epitheloid) (HYPH -) (JJ rich)) (JJ medullary) (NN zone))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NML (NML (NN 4G)) (PP (SYM –) (NP (NN I))))) (-RRB- -RRB-))) (. .)) )
( (S (NP-SBJ (NP (JJ Total) (JJ average) (NN cell) (NNS counts)) (PP (IN for) (NP (CD two) (NN control) (NNS thymi)))) (VP (VBD were) (NP-PRD (NP (NP (QP (CD 1.33) (SYM ×) (CD 108)) (NNS cells)) (PP (SYM /) (NP (NN ml)))) (-LRB- -LRB-) (NP (NP (QP (QP (CD 1.05) (SYM ×) (CD 108)) (CC and) (QP (CD 1.6) (SYM ×) (CD 108))) (NNS cells)) (PP (SYM /) (NP (NN ml))) (PP (IN in) (NP (DT the) (CD two) (JJ different) (NNS controls)))) (-RRB- -RRB-))) (. .)) )
( (S (NP-SBJ (NP (JJ Representative) (JJ histological) (NN analysis)) (PP (IN of) (NP (NP (DT the) (NNS thymi)) (PP (IN of) (NP (ADJP (NP (NN VEGF) (HYPH -) (NN A) (HYPH -) (CD 164)) (HYPH -) (VBN induced)) (NN mutant) (NNS adults))))) (PRN (-LRB- -LRB-) (NP (NN Table) (CD 1)) (-RRB- -RRB-))) (VP (VBD revealed) (NP (NP (NP (DT a) (JJ dramatic) (NN decrease)) (PP (IN in) (NP (NN cellularity)))) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBD correlated) (PP (IN with) (NP (PRP$ its) (VBN decreased) (NN size))))))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NML (NML (NN 4J)) (PP (SYM –) (NP (NN L))))) (-RRB- -RRB-))) (. .)) )
( (S (S (NP-SBJ (DT The) (NN mutant) (NNS thymi)) (VP (VBD lacked) (NP (JJ major) (JJ histological) (NNS distinctions)) (PP-LOC (IN between) (NP (DT the) (ADJP (JJ medullary) (CC and) (JJ cortical)) (NNS layers))))) (CC and) (S (NP-SBJ (NP (DT the) (JJ basophilic) (JJ cortical) (NN layer)) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBZ is) (ADVP-TMP (RB usually)) (ADJP-PRD (JJ rich) (PP (IN in) (NP (NNS thymocytes)))))))) (VP (VBD was) (ADJP-PRD (ADVP (RB almost) (RB completely)) (JJ absent)) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 4L)) (-RRB- -RRB-)))) (. .)) )
( (S (NP-SBJ (NP (JJ Total) (JJ average) (NN cell) (NNS counts)) (PP (IN for) (NP (CD three) (NN mutant) (NNS thymi)))) (VP (VBD were) (NP-PRD (NP (QP (CD 1.37) (SYM ×) (CD 107)) (NNS cells)) (PP (SYM /) (NP (NN ml))) (PRN (-LRB- -LRB-) (NP (NP (QP (QP (CD 3.9) (SYM ×) (CD 107)) (, ,) (QP (CD 8.1) (SYM ×) (CD 105)) (CC and) (QP (CD 1.14) (SYM ×) (CD 106))) (NNS cells)) (PP (SYM /) (NP (NN ml))) (PP (IN per) (NP (NN animal)))) (-RRB- -RRB-)))) (. .)) )
( (S (NP-SBJ (DT These) (NNS numbers)) (VP (MD may) (VP (RB under) (HYPH -) (VB represent) (NP (NP (DT the) (NN acellularity)) (PP (IN of) (NP (DT the) (NN mutant) (NNS thymi)))) (SBAR-PRP (IN as) (S (NP-SBJ (NP (CD two)) (PP (IN of) (NP (DT the) (JJR higher) (NNS values)))) (VP (VBD were) (PP-PRD (IN from) (NP (NP (DT the) (CD two) (NNS animals)) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBD survived) (NP (NP (DT the) (JJ initial) (NML (CD five) (HYPH -) (NN day)) (NN period)) (PP (IN of) (NP (NN doxycycline) (NN treatment)))))))))))))) (. .)) )
( (S (NP-SBJ (NP (DT The) (JJR lower) (NN cell) (NN count)) (PP (IN of) (NP (NP (QP (CD 8.1) (SYM ×) (CD 105)) (NNS cells)) (PP (SYM /) (NP (NN ml))))) (PP (IN from) (NP (NP (CD one)) (PP (IN of) (NP (NP (DT the) (JJ original) (JJ sick) (NNS animals)) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBD had) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB be) (VP (VBN euthanized) (NP-1 (-NONE- *)) (PP-TMP (IN in) (NP (DT the) (JJ first) (NML (CD five) (HYPH -) (NN day)) (NN period))))))))))))))) (VP (MD may) (VP (VB be) (ADJP-PRD (RBR more) (JJ representative) (PP (IN of) (NP (NP (DT the) (NN acellularity)) (VP (VBN shown) (NP (-NONE- *)) (PP (IN in) (NP (NN Figure) (NML (NML (NN 4J)) (PP (SYM –) (NP (NN L)))))))))))) (. .)) )
( (S (NP-SBJ (NP (DT The) (JJ thymic) (NN atrophy)) (VP (VBN presented) (NP (-NONE- *)) (PP (IN in) (NP (DT this) (NN paper))))) (VP (VBZ phenocopies) (NP (NP (JJ previous) (NNS reports)) (PP (VBG concerning) (NP (NP (NP (DT the) (JJ detrimental) (NNS effects)) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ (JJ systemic) (NN VEGF) (HYPH -) (NN A)) (VP (VBZ has) (NP-1 (-NONE- *T*)))))) (PP (IN on) (NP (NML (NN T) (HYPH -) (NN cell)) (NN development)))))) (PRN (-LRB- -LRB-) (NP (CD 33)) (-RRB- -RRB-))) (. .)) )
( (S (PP (IN In) (NP (NN addition))) (, ,) (NP-SBJ-1 (NP (JJ ubiquitous) (NN expression)) (PP (IN of) (NP (NN VEGF) (HYPH -) (NN A) (HYPH -) (CD 164))) (PP-TMP (IN during) (NP (JJ early) (NN development)))) (VP (VP (VBZ seems) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB give) (NP (NN rise)) (PP (IN to) (NP (NP (VBN increased) (NNS numbers)) (PP (IN of) (NP (NNS erythroblasts))))))))) (CC and) (VP (MD may) (VP (VB inhibit) (NP (NP (DT the) (NN differentiation)) (PP (IN of) (NP (DT these) (NNS progenitors))))))) (. .)) )
( (S (PP (IN From) (NP (DT this) (NN study))) (, ,) (NP-SBJ (NP (PRP it)) (SBAR-1 (-NONE- *EXP*))) (VP (VBZ is) (RB not) (ADJP-PRD (JJ clear)) (SBAR-1 (IN whether) (S (NP-SBJ-2 (DT this) (NN phenotype)) (VP (VBZ is) (VP (VBN caused) (NP-2 (-NONE- *)) (PP (PP (IN by) (NP-LGS (NP (NNS alterations)) (PP (IN in) (NP (DT the) (NML (NN yolk) (NN sac)) (NN environment))))) (CC or) (PP (IN by) (NP-LGS (NP (JJ artificial) (NML (NN VEGF) (HYPH -) (NN A) (HYPH -) (CD 164)) (JJ autocrine) (NN loop)) (VP (VBN created) (NP (-NONE- *))))))))))) (. .)) )
( (S (NP-SBJ (PRP We)) (VP (VBP are) (ADVP-TMP (RB currently)) (VP (VBG investigating) (NP (NP (DT the) (JJ molecular) (NNS mechanisms)) (PP (IN behind) (NP (NP (NP (NN VEGF) (HYPH -) (NN A) (POS 's)) (JJ suppressive) (NNS effects)) (PP (IN on) (NP (JJ different) (JJ hematopoietic) (NNS populations)))))) (PP-MNR (IN through) (NP (NP (DT the) (NN use)) (PP (IN of) (NP (NP (DT this) (JJ transgenic) (NN system)) (PP (ADVP (RB together)) (IN with) (NP (JJ additional) (JJ hematopoietic) (ADJP (NN lineage) (HYPH -) (JJ specific)) (NN Cre) (NNS lines))))))) (PRN (-LRB- -LRB-) (NP (CD 37) (, ,) (CD 38)) (-RRB- -RRB-)))) (. .)) )
( (S (S (NP-SBJ (DT The) (VBG developing) (JJ nervous) (NN system)) (VP (VBZ is) (ADVP (RB also)) (ADJP-PRD (JJ sensitive) (PP (IN to) (NP (VBN altered) (NML (NN VEGF) (HYPH -) (NN A)) (NN expression)))))) (, ,) (S (NP-SBJ (PRP We)) (VP (VBP have) (ADVP-TMP (RB recently)) (VP (VBN demonstrated) (SBAR (IN that) (S (NP-SBJ (NP (NP (NN downregulation)) (PP (IN of) (NP (NP (DT the) (NN level)) (PP (IN of) (NP (DT this) (NN growth) (NN factor)))))) (, ,) (VP (VBG using) (NP (NP (DT a) (NML (NN Nestin) (HYPH -) (NN Cre)) (NN transgene)) (CC and) (NP (NP (DT a) (JJ conditional) (VBN targeted) (NN allele)) (PP (IN of) (NP (NN VEGF) (HYPH -) (NN A))))))) (, ,) (VP (VBP have) (NP (NP (JJ severe) (NNS consequences)) (PP (IN to) (NP (JJ cortical) (NN vessel) (NML (NN density) (CC and) (NN structure))))) (PRN (-LRB- -LRB-) (NP (CD 39)) (-RRB- -RRB-)))))))) (. .)) )
( (S (NP-SBJ (NP (DT The) (NML (NML (NML (NN Nestin) (HYPH -) (NN CreTg)) (HYPH /) (NML (SYM +))) (, ,) (NML (NML (NN ROSA26) (HYPH -) (NN rtTA) (HYPH -) (NN IRES) (HYPH -) (NN EGFPTg)) (HYPH /) (NML (SYM +))) (, ,) (NML (NML (NN tet) (HYPH -) (NN O) (HYPH -) (NN VEGF) (HYPH -) (NN A) (HYPH -) (NN 164Tg)) (HYPH /) (NML (SYM +)))) (ADJP (JJ triple) (JJ transgenic)) (NNS embryos)) (VP (VBN presented) (NP (-NONE- *)) (ADVP (RB here)))) (VP (VBD developed) (NP (NP (JJ vascular) (NNS abnormalities)) (VP-1 (-NONE- *ICH*))) (PP-TMP (IN by) (NP (NN E12.5))) (, ,) (VP-1 (VBN associated) (NP (-NONE- *)) (PP (IN with) (NP (NML (NML (JJ spinal) (NN cord)) (CC and) (NML (NN brain))) (NNS hemorrhages)))) (, ,) (SBAR-TMP (WHADVP-3 (WRB when)) (S (NP-SBJ-2 (NN doxycycline)) (VP (VBD was) (VP (VBN administered) (NP-2 (-NONE- *)) (PP (IN to) (NP (PRP$ their) (NN mother))) (PP-TMP (IN from) (NP (NP (CD 1.5) (NN dpc)) (PP (IN of) (NP (NN pregnancy))))) (ADVP-TMP-3 (-NONE- *T*)))))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NML (NN 3H) (CC and) (NN I))) (-RRB- -RRB-))) (. .)) )
( (S (PP (IN Without) (NP (NP (NN doxycycline) (NN administration)) (PP (IN to) (NP (DT the) (NN mother))))) (, ,) (NP-SBJ (DT these) (NNS embryos)) (VP (VP (VBD developed) (ADVP (RB normally))) (CC and) (VP (VBD reached) (NP (NN adulthood)))) (. .)) )
( (S (ADVP (RB Interestingly)) (, ,) (SBAR-TMP (WHADVP-1 (WRB when)) (S (NP-SBJ (DT these) (NNS mice)) (VP (VBD received) (NP (NN doxycycline)) (PP-TMP (IN for) (NP (CD 5) (NNS days))) (PP-TMP (IN at) (NP (NP (CD 4) (NNS months)) (PP (IN of) (NP (NN age))))) (ADVP-TMP-1 (-NONE- *T*))))) (, ,) (NP-SBJ (PRP they)) (VP (VBD did) (RB not) (VP (VB show) (NP (DT any) (JJ obvious) (JJ gross) (ADJP (JJ behavioral) (CC or) (JJ phenotypic)) (NNS abnormalities)))) (. .)) )
( (S (NP-SBJ (NP (JJ Initial) (UCP (NN vessel) (CC and) (JJ histological)) (NN analysis)) (PP (IN from) (NP (QP (CD two) (IN of) (DT the) (CD six)) (VBN treated) (JJ adult) (NN mouse) (NNS brains)))) (VP (VBD did) (RB not) (VP (VB reveal) (NP (NP (DT any) (JJ striking) (NNS differences)) (PP (IN in) (NP (NP (NN vessel) (NN architecture)) (CC or) (NP (NP (JJ structural) (NN organization)) (PP (IN of) (NP (DT the) (NN cortex))))))) (PRN (-LRB- -LRB-) (S (NP-SBJ-1 (NNS data)) (RB not) (VP (VBN shown) (NP-1 (-NONE- *)))) (-RRB- -RRB-)))) (. .)) )
( (S (NP-SBJ (DT This) (NN result)) (VP (MD may) (VP (VB indicate) (NP (NP (DT an) (VBN increased) (NN resistance)) (PP (IN of) (NP (DT the) (JJ adult) (NN CNS) (NN vasculature))) (PP (IN to) (NP (NN VEGF) (HYPH -) (NN A)))))) (. .)) )
( (S (NP-SBJ (PRP We)) (VP (VBP are) (ADVP-TMP (RB currently)) (ADVP (RB further)) (VP (VBG examining) (NP (NP (NP (DT the) (JJ potential) (NNS effects)) (PP (IN of) (NP (NP (ADJP (NN doxycycline) (HYPH -) (VBN induced)) (NNS increases)) (PP (IN of) (NP (NN VEGF) (HYPH -) (NN A) (HYPH -) (CD 164)))))) (CC and) (NP (NP (PRP$ its) (NNS effects)) (PP (IN on) (NP (DT the) (ADJP (VBG developing) (CC and) (JJ adult)) (JJ nervous) (NN system))))) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (DT this) (ADJP (JJ triple) (JJ transgenic)) (NN system)))))) (. .)) )
( (S (PP (IN In) (NP (NN contrast))) (, ,) (NP-SBJ (NP (DT the) (NML (NML (NML (NN Podocin) (HYPH -) (NN CreTg)) (HYPH /) (NML (SYM +))) (, ,) (NML (NML (NN ROSA26) (HYPH -) (NN rtTA) (HYPH -) (NN IRES) (HYPH -) (NN EGFPTg)) (HYPH /) (NML (SYM +))) (, ,) (NML (NML (NN tet) (HYPH -) (NN O) (HYPH -) (NN VEGF) (HYPH -) (NN A) (HYPH -) (NN 164Tg)) (HYPH /) (NML (SYM +)))) (ADJP (JJ triple) (JJ transgenic)) (NNS mice)) (VP (VBN treated) (NP (-NONE- *)) (PP-MNR (IN with) (NP (NN doxycycline))) (PP-TMP (IN for) (NP (CD 7) (NNS days))) (S-ADV (NP-SBJ (-NONE- *PRO*)) (VP (VBG starting) (PP-TMP (IN at) (NP (NP (CD 4) (NNS months)) (PP (IN of) (NP (NN age))))))))) (VP (VBD developed) (NP (NN proteinuria)) (PRN (-LRB- -LRB-) (NP (NP (NN albumin)) (ADJP (SYM >) (NP (NP (CD 5) (NN g)) (PP (SYM /) (NP (NN l)))))) (, ,) (S (NP-SBJ-1 (NNS data)) (RB not) (VP (VBN shown) (NP-1 (-NONE- *)))) (-RRB- -RRB-))) (. .)) )
( (S (NP-SBJ-1 (NP (DT The) (NN presence)) (PP (IN of) (NP (NN albuminuria))) (PP (IN in) (NP (NP (NNS concentrations)) (ADJP (SYM >) (NP (NP (CD 3) (NN g)) (PP (SYM /) (NP (NN l)))))))) (VP (VBZ is) (VP (VBN designated) (NP-1 (-NONE- *)) (`` ‘) (S-CLR (NP-SBJ-1 (-NONE- *PRO*)) (NP-PRD (JJ nephrotic) (NN range) (NN proteinuria))) ('' ’))) (. .)) )
( (S (NP-SBJ (NP (DT This) (NN degree)) (PP (IN of) (NP (NN proteinuria)))) (VP (VBZ represents) (NP (NP (NN loss)) (PP (IN of) (NP (NP (DT the) (JJ permeselective) (NN function)) (PP (IN of) (NP (DT the) (JJ glomerular) (NN filtration) (NN barrier))))))) (. .)) )
( (S (NP-SBJ-1 (NP (VBN Increased) (NN permeability)) (PP-LOC (IN in) (NP (DT the) (NN glomerulus)))) (VP (VP (VBZ leads) (PP (IN to) (NP (NP (DT the) (NN loss)) (PP (IN of) (NP (NP (JJ critical) (NN blood) (NN proteins)) (, ,) (PP (VBG including) (NP (NP (NN albumin)) (, ,) (NP (NML (NN blood) (NN clotting)) (NN factor) (NNS inhibitors)) (CC and) (NP (NNS lipids))))))))) (, ,) (CC and) (VP (VBZ is) (VP (VBN associated) (NP-1 (-NONE- *)) (PP (IN with) (NP (NP (NN edema)) (CC and) (NP (JJ thrombotic) (NNS events)))) (PP-LOC (IN in) (NP (NNS patients)))))) (. .)) )
( (S (NP-SBJ (DT These) (NNS mice)) (VP (VBP are) (ADVP-TMP (RB currently)) (PP-PRD (IN under) (NP (JJ detailed) (JJ phenotypic) (NN analysis))) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB identify) (NP (NP (DT the) (NN nature)) (PP (IN of) (NP (NP (NP (NNS changes)) (PP-LOC (IN in) (NP (DT the) (NN kidney)))) (VP (VBN caused) (NP (-NONE- *)) (PP (IN by) (NP-LGS (NN induction) (NML (NN VEGF) (HYPH -) (NN A)) (NN expression))) (PP-LOC (IN in) (NP (NNS podocytes))))))))))) (. .)) )
( (S (NP-SBJ (NN Table) (CD 1)) (VP (VBZ displays) (NP (NP (DT the) (NNS results)) (PP (IN of) (NP (NP (PDT all) (DT the) (NNS experiments)) (VP (VBN described) (NP (-NONE- *)) (ADVP (RB above))))))) (. .)) )
( (S (PP (IN In) (NP (NN summary))) (, ,) (PP-MNR (IN by) (S-NOM (NP-SBJ-1 (-NONE- *PRO*)) (VP (VBG combining) (NP (NP (JJ existing) (ADJP (NN tissue) (HYPH -) (JJ specific)) (ADJP (NN Cre) (HYPH -) (JJ transgenic)) (NN mouse) (NNS strains) (PRN (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB define) (NP (JJ spatial) (NML-2 (-NONE- *RNR*)))))))) (, ,) (CC and) (NP (DT the) (ADJP (NN tetracycline) (HYPH -) (JJ inducible)) (NN system) (PRN (S (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB define) (NP (JJ temporal) (NML-2 (-NONE- *RNR*)))))))) (NML-2 (NML (NN aspect)) (PP (IN of) (NP (NN transgene) (NN expression)))))))) (, ,) (NP-SBJ-1 (PRP we)) (VP (VBP have) (VP (VBN developed) (NP (NP (DT a) (JJ versatile) (NN system)) (SBAR (WHNP-3 (WDT which)) (S (NP-SBJ-3 (-NONE- *T*)) (VP (VBZ allows) (NP (NP (ADJP (JJ quick) (CC and) (JJ efficient)) (NN investigation)) (PP (IN of) (NP (JJ multiple) (NN gene) (NNS functions)))))))))) (. .)) )
( (S (NP-SBJ-1 (DT This) (NN aim)) (VP (VBZ has) (ADVP (RB also)) (VP (VBN been) (VP (VBN addressed) (NP-1 (-NONE- *)) (PP (IN by) (NP-LGS (NNS others))) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (ADJP (NN hormone) (HYPH -) (VBN activated)) (NN Cre) (NN proteins)))) (PRN (-LRB- -LRB-) (NP (CD 40) (, ,) (CD 41)) (-RRB- -RRB-))))) (. .)) )
( (S (NP-SBJ (NP (DT The) (JJ major) (NN advantage)) (PP (IN of) (NP (DT these) (JJR earlier) (NNS efforts)))) (VP (VBP lie) (SBAR-ADV (IN in) (IN that) (S (NP-SBJ-1 (RB only) (CD two) (NNS transgenes)) (VP (VBP have) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB be) (VP (VBN combined) (NP-1 (-NONE- *)))))))))) (. .)) )
( (S (ADVP (RB However)) (, ,) (NP-SBJ (PRP$ our) (NN system)) (VP (VBZ allows) (PP (IN for) (NP (NP (JJ complete) (ADJP (JJ on) (HYPH /) (JJ off)) (NN control)) (PP (IN of) (NP (NN expression)))))) (. .)) )
( (S (PP (IN In) (NP (NN addition))) (, ,) (NP-SBJ-1 (DT the) (VBG existing) (JJ inducible) (NNS systems)) (VP (MD can) (RB not) (VP (VP (VB be) (VP (VBN combined) (NP-1 (-NONE- *)) (PP (IN with) (NP-2 (-NONE- *RNR*))))) (CC and) (VP (VB take) (NP (NN advantage)) (PP (IN of) (NP-2 (-NONE- *RNR*)))) (NP-2 (NP (DT the) (JJ large) (NN number)) (PP (IN of) (NP (NP (VBG existing) (ADJP (NN Cre) (HYPH -) (JJ transgenic)) (NN mouse) (NNS strains)) (VP (VBG defining) (NP (NML (NML (NN tissue) (HYPH /) (NN cell)) (NNS type)) (HYPH -) (NNS specificities)))))))) (. .)) )
( (S (NP-SBJ (PRP$ Our) (NNS results)) (VP (VBP show) (SBAR (IN that) (S (SBAR-TMP (WHADVP-1 (WRB when)) (S (NP-SBJ-2 (-NONE- *PRO*)) (VP (VBN expressed) (NP-2 (-NONE- *)) (PP (IN from) (NP (DT the) (NN ROSA26) (NN locus))) (ADVP-TMP-1 (-NONE- *T*))))) (, ,) (NP-SBJ-3 (NP (DT the) (NN baseline) (NN activity)) (PP (IN of) (NP (NN rtTA))) (PP (IN in) (NP (NP (DT the) (NN absence)) (PP (IN of) (NP (NN inducer)))))) (VP (VBZ is) (RB not) (ADJP-PRD (JJ sufficient) (S (NP-SBJ-3 (-NONE- *PRO*)) (VP (TO to) (VP (VB cause) (NP (NP (JJ significant) (NN activation)) (PP (IN of) (NP (DT a) (JJ responsive) (NN promoter)))))))))))) (. .)) )
( (S (NP-SBJ (DT This)) (VP (VBZ is) (PP-PRD (IN in) (NP (NP (NN agreement)) (PP (IN with) (NP (NP (DT the) (NNS findings)) (PP (IN of) (NP (NP (NNP Wutz) (CC and) (NNP Jaenisch)) (PRN (-LRB- -LRB-) (NP (CD 42)) (-RRB- -RRB-)) (, ,) (SBAR (WHNP-1 (WP who)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBD used) (NP (NP (JJ constitutive) (NN rtTA) (NN expression)) (PP (IN from) (NP (DT the) (NN ROSA26) (NN promoter)))))))))))))) (. .)) )
( (S (NP-SBJ (PRP We)) (VP (VBP expect) (ADVP (RB though)) (SBAR (IN that) (S (NP-SBJ (DT the) (NN ROSA26) (ADJP (NN locus) (VBN placed)) (NN rtTA)) (VP (MD could) (VP (VB be) (NP-PRD (DT a) (NN limitation)) (PP-MNR (IN by) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG providing) (NP (NP (NP (RB only) (DT a) (JJ given) (NN level)) (PP (IN of) (NP (NP (NN expression)) (PP (IN for) (NP (NN rtTA)))))) (, ,) (SBAR (WHNP-2 (WDT which)) (S (NP-SBJ-2 (-NONE- *T*)) (VP (MD might) (RB not) (VP (VB be) (ADJP-PRD (JJ high) (RB enough) (S (NP-SBJ-2 (-NONE- *PRO*)) (VP (TO to) (VP (VB reach) (NP (NP (JJ sufficient) (NN level)) (PP (IN of) (NP (NP (NN induction)) (PP (IN of) (NP (JJ different) (NN responder) (NML (NN tet) (HYPH -) (NN O)) (HYPH -) (NNS genes)))))) (PP-LOC (IN in) (NP (JJ certain) (NML (NML (JJ anatomical) (NNS areas)) (CC or) (NML (NN cell) (NNS types)))))))))))))))))))))) (. .)) )
( (S (ADVP (RB Therefore)) (, ,) (NP-SBJ (NP (DT an) (JJ obvious) (NN future) (NN improvement)) (PP (IN of) (NP (DT the) (VBN presented) (NN system)))) (VP (MD would) (VP (VB be) (NP-PRD (NP (DT the) (NN establishment)) (PP (IN of) (NP (ADJP (NN Cre) (JJ conditional)) (NN rtTA) (NNS transgenes))) (PP (IN in) (NP (NP (JJ several) (JJ genomic) (NNS positions)) (ADJP (JJ permissive) (PP (IN to) (NP (NP (JJ different) (NN level)) (PP (IN of) (NP (JJ overall) (NN expression))))))))))) (. .)) )
( (S (NP-SBJ (PRP$ Our) (ADJP (NN ROSA26) (VBN placed)) (ADJP (NN Cre) (HYPH -) (JJ conditional)) (NN system)) (VP (MD could) (VP (VB be) (NP-PRD (NP (DT the) (JJ first) (NN member)) (PP (IN of) (NP (DT this) (VBN envisioned) (JJ useful) (NN series)))))) (. .)) )
( (HEADING (NP (NNS Acknowledgements))) )
( (S (NP-SBJ (PRP We)) (VP (VP (VBP are) (ADJP-PRD (JJ grateful) (PP=1 (IN to) (NP (NNP Dr) (NNP C.) (NNP G.) (NNP Lobe)))) (PP-PRP=2 (IN for) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG providing) (NP (DT the) (NN pCALL2) (HYPH -) (NN IRES) (HYPH -) (NN EGFP)))))) (CC and) (VP (PP=1 (IN to) (NP (NNP Dr) (NNP H.) (NNP Bujard))) (PP-PRP=2 (IN for) (NP (DT the) (NML (NN pBI) (HYPH -) (CD 3)) (NNS vectors))))) (. .)) )
( (S (NP-SBJ-1 (DT These) (NNS studies)) (VP (VBD were) (VP (VBN supported) (NP-1 (-NONE- *)) (PP (IN in) (ADJP (JJ part))) (PP (IN by) (NP-LGS (NP (DT a) (NML (NML (NNP National) (NNP Cancer) (NNP Institute)) (PP (IN of) (NP (NNP Canada)))) (NN grant)) (-LRB- -LRB-) (NP (NN NCIC) (NN grant) (CD 21335)))))) (-RRB- -RRB-) (. .)) )
( (S (NP-SBJ (NNP J.H.)) (VP (VBD was) (NP-PRD (NP (DT a) (NN recipient)) (PP (IN of) (NP (DT an) (NN NCIC) (JJ postdoctoral) (NN fellowship))))) (. .)) )
( (S (NP-SBJ (NNP A.N.)) (VP (VBZ is) (NP-PRD (DT a) (JJ senior) (NML (NML (NML (NNP Canadian) (NNPS Institutes)) (PP (IN of) (NP (NNP Health) (NNP Research)))) (-LRB- -LRB-) (NML (NNP CIHR))) (-RRB- -RRB-) (NN scientist))) (. .)) )
( (S (NP-SBJ-1 (NNP S.E.Q.)) (VP (VBZ is) (VP (VBN supported) (NP-1 (-NONE- *)) (PP (IN by) (NP-LGS (NN CIHR) (NN grant) (NN no.) (CD 62931))))) (. .)) )
( (S (NP-SBJ-1 (NP (NN Funding)) (SBAR (WHNP-2 (-NONE- *0*)) (S (NP-SBJ-2 (-NONE- *T*)) (VP (TO to) (VP (VB pay) (NP (DT the) (NML (JJ Open) (NN Access)) (NN publication) (NNS charges)) (PP-PRP (IN for) (NP (DT this) (NN article)))))))) (VP (VBD was) (VP (VBN provided) (NP-1 (-NONE- *)) (PP (IN by) (NP-LGS (NN NCIC) (CD 021335))))) (. .)) )
( (HEADING (NP (NML (NML (NN Conflict)) (PP (IN of) (NP (NN interest)))) (NN statement) (. .))) )
( (FRAG (NP (NP (NN None)) (VP (VBN declared) (NP (-NONE- *)))) (. .)) )
( (HEADING (NP (NNS Figures) (CC and) (NNS Tables))) )
( (HEADING (NP (NN Figure) (CD 1))) )
( (CAPTION (NP (NP (VBN Targeted) (NN insertion)) (PP (IN of) (NP (DT a) (JJ conditional) (NML (NN rtTA) (HYPH -) (NN IRES) (HYPH -) (NN EGFP)) (NN transgene))) (PP (IN into) (NP (DT the) (NN ROSA26) (NN locus))) (. .))) )
( (CAPTION (NP (LST (-LRB- -LRB-) (LS A) (-RRB- -RRB-)) (NN Targeting) (NN strategy) (. .))) )
( (CAPTION (S (S (NP-SBJ-1=2 (NP (DT The) (NNS exons)) (PP (IN of) (NP (DT the) (NN ROSA26) (NN gene)))) (VP (VBP are) (VP (VBN depicted) (NP-1 (-NONE- *)) (PP-MNR=3 (IN as) (NP (VBN numbered) (NNS boxes)))))) (, ,) (CC and) (S (NP-SBJ=2 (DT the) (NNS triangles)) (PP-MNR=3 (IN as) (NP (NN loxP) (NNS sites)))) (. .))) )
( (CAPTION (S (NP-SBJ-1 (NP (DT The) (NN insertion) (NN point) (PRN (-LRB- -LRB-) (NP (NN XbaI) (NN site)) (-RRB- -RRB-))) (, ,) (NP (JJ informative) (NN restriction) (NNS sites)) (CC and) (NP (JJ diagnostic) (NNS fragments))) (VP (VBP are) (ADVP (RB also)) (VP (VBN shown) (NP-1 (-NONE- *)))) (. .))) )
( (CAPTION (S (NP-SBJ-1 (NNS Abbreviations)) (VP (VBP are) (VP (VBN explained) (NP-1 (-NONE- *)) (PP (IN in) (NP (DT the) (NN text))))) (. .))) )
( (CAPTION (S (NP-SBJ (NN Drawing)) (VP (VBZ is) (RB not) (PP-PRD (IN to) (NP (NN scale)))) (. .))) )
( (CAPTION (FRAG (NP (LST (-LRB- -LRB-) (LS B) (-RRB- -RRB-)) (NP (NML (NNP Southern) (HYPH -) (NN blot)) (NN analysis)) (PP (IN of) (NP (NP (JJ genomic) (NN DNA)) (PP (IN from) (NP (NP (NN ES) (NNS cells)) (VP (VP (VBN digested) (NP (-NONE- *)) (PP-MNR (IN by) (NP (NN EcoRV)))) (CC and) (VP (VBD hybridized) (NP (-NONE- *)) (PP-MNR (IN with) (NP (DT a) (NML (CD 5) (SYM ′)) (NML (NML (JJ external) (NN probe) (PRN (-LRB- -LRB-) (ADJP (JJ left)) (-RRB- -RRB-))) (CC and) (NML (NN neo) (NN probe) (PRN (-LRB- -LRB-) (ADJP (JJ right)) (-RRB- -RRB-))))))))))))) (S (LST (-LRB- -LRB-) (LS C) (-RRB- -RRB-)) (PP-TMP (IN After) (NP (NN Cre) (HYPH -) (NN excision))) (, ,) (NP-SBJ (NNS cells)) (VP (VBP show) (NP (JJ green) (NN fluroescence)))) (. .))) )
( (CAPTION (S (NP-SBJ-1 (NN Line) (NN 1C12)) (VP (VBD was) (VP (VBN transfected) (NP-1 (-NONE- *)) (PP-MNR (IN with) (NP (NP (DT a) (NN plasmid)) (VP (VBG carrying) (NP (NML (NN Cre) (CC and) (NN puro)) (NN expression) (NNS cassettes))))))) (. .))) )
( (CAPTION (S (NP-SBJ-1 (DT A) (ADJP (NN puromycin) (HYPH -) (JJ resistant)) (NN colony)) (VP (VBZ is) (VP (VBN shown) (NP-1 (-NONE- *)))) (. .))) )
( (CAPTION (NP (LST (-LRB- -LRB-) (LS D) (CC and) (LS E) (-RRB- -RRB-)) (NP (NN Tetracyclin) (HYPH -) (NN induction)) (PP (IN of) (NP (NN lacZ))) (PP-LOC (IN in) (NP (ADJP (NN Cre) (HYPH -) (VBN excised)) (NN 1C12) (NNS cells))) (. .))) )
( (CAPTION (S (NP-SBJ-1 (DT The) (NNS cells)) (VP (VBD were) (VP (VBN transfected) (NP-1 (-NONE- *)) (PP-MNR (IN with) (NP (NP (DT a) (NN plasmid)) (VP (VBG containing) (NP (DT a) (NML (NML (NN tet) (HYPH -) (NN O)) (HYPH -) (NN lacZ)) (NN transgene))))))) (. .))) )
( (CAPTION (NP (LST (-LRB- -LRB-) (LS D) (-RRB- -RRB-)) (DT No) (NN doxycycline) (NN induction) (. .))) )
( (CAPTION (NP (LST (-LRB- -LRB-) (LS E) (-RRB- -RRB-)) (NP (NNS Cells)) (PP-TMP (IN after) (NP (NN doxycycline) (NN administration) (PRN (-LRB- -LRB-) (NP (NP (CD 100) (NN ng)) (PP (SYM /) (NP (NN ml))) (PP-TMP (IN for) (NP (CD 2) (NNS days)))) (-RRB- -RRB-)))) (. .))) )
( (HEADING (NP (NN Figure) (CD 2))) )
( (CAPTION (NP (NP (NN Operation)) (PP (IN of) (NP (DT the) (ADJP (NP (NN Cre) (HYPH /) (NN loxP)) (HYPH -) (JJ dependent)) (, ,) (ADJP (NN tetracycline) (JJ inducible)) (JJ transgenic) (NN system))) (. .))) )
( (CAPTION (S (LST (-LRB- -LRB-) (LS A) (-RRB- -RRB-)) (NP-SBJ-2 (NP (NNS Mice)) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBP are) (ADJP-PRD (JJ homozygous) (PP (IN for) (NP (NP (DT the) (VBN targeted) (NN insertion)) (PP (IN of) (NP (DT the) (JJ conditional) (NML (NN rtTA) (HYPH -) (NN IRES) (HYPH -) (NN EGFP)) (JJ bicistronic) (NN transgene))) (PP-LOC (IN at) (NP (NN ROSA26)))))))))) (VP (MD can) (VP (VB be) (VP (VBN bred) (NP-2 (-NONE- *)) (PP-MNR (IN with) (NP (NP (ADJP (JJ double) (JJ transgenic)) (NNS mice)) (SBAR (WHNP-3 (WDT that)) (S (NP-SBJ-3 (-NONE- *T*)) (VP (VBP carry) (NP (NP (DT a) (ADJP (NN tissue) (HYPH -) (JJ specific)) (NN Cre) (NN transgene)) (CC and) (NP (DT a) (ADJP (NN doxycycline) (HYPH -) (JJ inducible)) (ADJP (NN rtTA) (HYPH -) (JJ dependent)) (NML (NML (NN tet) (HYPH -) (NN O)) (HYPH -) (NN GENE)) (NN responder) (NN line))))))))))) (. .))) )
( (CAPTION (S (NP-SBJ (NP (DT A) (NN total)) (PP (IN of) (NP (NP (CD 25) (NN %)) (PP (IN of) (NP (DT the) (NNS pups)))))) (VP (MD will) (VP (VB be) (ADJP-PRD (JJ triple) (JJ transgenic)) (PRN (-LRB- -LRB-) (NP (NP (NN SpecPromoterCreTg) (HYPH /) (SYM +)) (, ,) (NP (NP (NN ROSA26) (HYPH -) (NN STOP) (HYPH -) (NN rtTA) (HYPH -) (NN IRES) (HYPH -) (NN EGFPTg)) (HYPH /) (NP (SYM +))) (, ,) (NP (NP (NML (NN tet) (HYPH -) (NN O)) (HYPH -) (NN GENETg)) (HYPH /) (NP (SYM +)))) (-RRB- -RRB-)))) (. .))) )
( (CAPTION (S (LST (-LRB- -LRB-) (LS B) (-RRB- -RRB-)) (S (PP-LOC (IN In) (NP (NP (NNS cells)) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBP do) (RB not) (VP (VB express) (NP (NN Cre)))))))) (, ,) (NP-SBJ-2 (CC neither) (NP (NN rtTA)) (CC nor) (NP (NN EGFP) (NN protein))) (VP (VBZ is) (VP (VBN generated) (NP-2 (-NONE- *))))) (: ;) (S (ADVP (RB therefore)) (, ,) (NP-SBJ (DT the) (NML (NN tet) (HYPH -) (NN O)) (HYPH -) (NN GENE)) (VP (VBZ is) (ADJP-PRD (JJ silent)))) (. .))) )
( (CAPTION (S (LST (-LRB- -LRB-) (LS C) (-RRB- -RRB-)) (PP-LOC (IN In) (NP (ADJP (NN Cre) (HYPH -) (VBG expressing)) (NNS cells))) (, ,) (NP-SBJ-1 (NML (NN rtTA) (CC and) (NN EGFP)) (NN expression)) (VP (VBZ is) (VP (VBN turned) (NP-1 (-NONE- *)) (PRT (RP on)))) (. .))) )
( (S (ADVP (RB However)) (, ,) (PP (IN in) (NP (NP (DT the) (NN absence)) (PP (IN of) (NP (NP (DT an) (NN inducer)) (-LRB- -LRB-) (NP (ADVP (FW e.g.)) (NN doxycycline)) (-RRB- -RRB-))))) (, ,) (NP-SBJ (NN rtTA)) (VP (MD can) (RB not) (VP (VB activate) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (DT the) (NML (NML (NN tet) (HYPH -) (NN O)) (HYPH -) (NN GENE)) (NN target)))))) (. .)) )
( (S (NP-SBJ (NP (NN Addition)) (PP (IN of) (NP (NN doxycycline)))) (VP (VBZ results) (PP (IN in) (NP (NP (NP (DT the) (NN formation)) (PP (IN of) (NP (DT an) (JJ active) (NN transactivator)))) (CC and) (NP (NP (NN expression)) (PP (IN of) (NP (DT the) (NN target) (NN gene))))))) (. .)) )
( (S (PP (IN In) (NP (DT the) (JJ present) (NN study))) (, ,) (NP-SBJ-1 (NN VEGF) (HYPH -) (NN A) (HYPH -) (CD 164)) (VP (VBD was) (VP (VBN induced) (NP-1 (-NONE- *)) (ADVP (CC either) (ADVP (RB ubiquitously)) (CC or) (ADVP (NP (NP (JJ nervous) (NN system)) (CC or) (NP (NN podocyte))) (RB specifically))) (PP (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NN doxycycline))))))) (. .)) )
( (HEADING (NP (NN Figure) (CD 3))) )
( (S (S (NP-SBJ (NP (ADJP (NN Tissue) (HYPH -) (JJ specific)) (NN expression)) (PP (IN of) (NP (DT the) (NML (NN rtTA) (HYPH -) (NN IRES) (HYPH -) (NN EGFP)) (JJ bicistronic) (NN transgene)))) (VP (VBZ is) (ADJP-PRD (NN Cre) (HYPH -) (JJ dependent)))) (CC and) (S (NP-SBJ-1 (NP (DT the) (NN rtTA) (NN trans) (HYPH -) (NN activation)) (PP (IN of) (NP (NML (NN tet) (HYPH -) (NN O)) (HYPH -) (NN VEGF) (HYPH -) (NN A) (HYPH -) (CD 164)))) (VP (VBZ is) (ADVP (RB tightly)) (VP (VBN regulated) (NP-1 (-NONE- *)) (PP (IN by) (NP-LGS (NN doxycycline)))))) (. .)) )
( (CAPTION (NP (NP (LST (-LRB- -LRB-) (LS A) (SYM –) (LS C) (-RRB- -RRB-)) (NP (NNS Images)) (PP (IN of) (NP (NP (JJ triple) (JJ transgenic) (NML (NML (NML (NN pCAGGS) (HYPH -) (NN CreTg)) (HYPH /) (NML (SYM +))) (, ,) (NML (NML (NN ROSA26) (HYPH -) (NN rtTA) (HYPH -) (NN IRES) (HYPH -) (NN EGFPTg)) (HYPH /) (NML (SYM +))) (, ,) (NML (NML (NN tet) (HYPH -) (NN O) (HYPH -) (NN VEGF) (HYPH -) (NN A) (HYPH -) (NN 164Tg)) (HYPH /) (NML (SYM +)))) (NN E9.5) (NML (NML (NN embryo)) (CC and) (NML (NN yolk) (NN sac)))) (PP (IN in) (NP (NP (DT the) (NN absence)) (PP (IN of) (NP (NN doxycycline)))))))) (: :) (NP (NP (LST (-LRB- -LRB-) (LS A) (-RRB- -RRB-)) (, ,) (NML (JJ Whole) (NN mount)) (NML (JJ bright) (NN field)) (NN microscopy)) (: ;) (NP (LST (-LRB- -LRB-) (LS B) (-RRB- -RRB-)) (, ,) (NML (NN GFP) (NN fluorescence)) (NN microscopy)) (: ;) (CC and) (NP (LST (-LRB- -LRB-) (LS C) (-RRB- -RRB-)) (, ,) (NP (NML (NN H) (CC &) (NN E)) (JJ histological) (NN section)) (PP (IN of) (NP (DT the) (NN yolk) (NN sac))))) (. .))) )
( (S (PP (IN In) (NP (NP (DT the) (NN absence)) (PP (IN of) (NP (NN doxycycline))))) (, ,) (NP-SBJ (ADJP (JJ triple) (JJ transgenic)) (NNS embryos)) (VP (VBP develop) (ADVP (RB normally))) (. .)) )
( (CAPTION (S (NP-SBJ (NP (NN Arrow)) (PP (IN in) (NP (-LRB- -LRB-) (NN A)))) (-RRB- -RRB-) (VP (VBZ shows) (NP (NP (JJ normal) (NML (NN yolk) (NN sac)) (NN vessel)) (PP (IN with) (NP (NP (NP (JJ primitive) (ADJP (NN hemoglobin) (HYPH -) (VBG containing)) (NNS RBCs)) (CC and) (NP (JJ normal) (NML (NML (NN blood) (NN island)) (-LRB- -LRB-) (NML (NN BI))) (-RRB- -RRB-) (NN formation))) (PP-LOC (IN between) (NP (NP (DT the) (JJ primitive) (NML (NML (NML (NN endoderm)) (-LRB- -LRB-) (NML (NN e))) (-RRB- -RRB-) (CC and) (NML (NML (NN mesoderm)) (-LRB- -LRB-) (NML (NN m)))) (-RRB- -RRB-) (NNS layers)) (PP (IN of) (NP (DT the) (NN yolk) (NN sac)))))))) (PRN (-LRB- -LRB-) (NP (NN C)) (-RRB- -RRB-))) (. .))) )
( (CAPTION (NP (LST (-LRB- -LRB-) (LS D) (SYM –) (LS F) (-RRB- -RRB-)) (NP (ADJP (JJ Triple) (JJ transgenic)) (NML (NML (NN embryo)) (CC and) (NML (NN yolk) (NN sac)))) (, ,) (NP (NP (DT the) (NN mother)) (VP (VBN treated) (NP (-NONE- *)) (PP-MNR (IN with) (NP (NN doxycycline))))) (. .))) )
( (CAPTION (NP (NP (LST (-LRB- -LRB-) (LS D) (-RRB- -RRB-)) (, ,) (NML (JJ Whole) (NN mount)) (NML (JJ bright) (NN field)) (NN microscopy)) (: ;) (NP (LST (-LRB- -LRB-) (LS E) (-RRB- -RRB-)) (, ,) (NML (NN GFP) (NN fluorescence)) (NN microscopy)) (: ;) (CC and) (NP (LST (-LRB- -LRB-) (LS F) (-RRB- -RRB-)) (, ,) (NP (NML (NN H) (CC &) (NN E)) (JJ histological) (NN section)) (PP (IN of) (NP (DT the) (NN yolk) (NN sac)))) (. .))) )
( (CAPTION (S (LST (-LRB- -LRB-) (LS D) (-RRB- -RRB-)) (PP (IN In) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NN doxycycline))))) (NP-SBJ (DT the) (ADJP (JJ triple) (JJ transgenic)) (NNS embryos)) (VP (VBP show) (NP (NP (DT a) (JJ lethal) (NN phenotype)) (PP (IN with) (NP (NP (NP (DT no) (JJ proper) (NN vessel) (NN development)) (PP-LOC (IN in) (NP (DT the) (NML (NML (NML (NN yolk) (NN sac)) (-LRB- -LRB-) (NML (NN ys))) (-RRB- -RRB-) (CC and) (NML (NML (NN embryo)) (-LRB- -LRB-) (NML (NN e))))))) (-RRB- -RRB-) (, ,) (NP (DT no) (ADJP (NN hemoglobin) (HYPH -) (VBG containing)) (NN RBC) (PRN (-LRB- -LRB-) (NP (NN D)) (-RRB- -RRB-))) (CC and) (NP (NP (JJ abnormal) (NML (NML (NN blood) (NN island)) (-LRB- -LRB-) (NML (NN BI))) (-RRB- -RRB-) (NNS structures)) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBP are) (VP (VBN filled) (NP-1 (-NONE- *)) (PP-MNR (IN with) (NP (JJ excessive) (JJ nucleated) (NML (NML (NNS erythroblasts)) (-LRB- -LRB-) (NML (NN EB)))))))))))))) (-RRB- -RRB-) (. .))) )
( (CAPTION (S (LST (-LRB- -LRB-) (LS B) (CC and) (LS E) (-RRB- -RRB-)) (NP-SBJ (DT The) (JJ overall) (NN EGFP) (NN signal)) (VP (VBZ marks) (NP (DT the) (JJ overall) (NN rtTA) (NN expression)) (PP-LOC (IN in) (NP (NP (DT the) (NML (NML (NN yolk) (NN sac)) (CC and) (NML (NN embryo)))) (PP (IN of) (NP (DT the) (ADJP (JJ triple) (JJ transgenic)) (NNS embryos)))))) (. .))) )
( (CAPTION (S (LST (-LRB- -LRB-) (LS G) (-RRB- -RRB-)) (NP-SBJ (NN E10.5) (ADJP (JJ triple) (JJ transgenic)) (NML (NML (NML (NN Nestin) (HYPH -) (NN CreTg)) (HYPH /) (NML (SYM +))) (, ,) (NML (NML (NN ROSA26) (HYPH -) (NN rtTA) (HYPH -) (NN IRES) (HYPH -) (NN EGFPTg)) (HYPH /) (NML (SYM +))) (, ,) (NML (NML (NML (NN tet) (HYPH -) (NN O)) (HYPH -) (NN VEGF) (HYPH -) (NN A) (HYPH -) (NN 164Tg)) (HYPH /) (NML (SYM +)))) (NNS embryos)) (VP (VP (VBP develop) (ADVP-MNR (RB normally)) (PP (IN in) (NP (NP (DT the) (NN absence)) (PP (IN of) (NP (NN doxycycline)))))) (CC and) (VP (VBP show) (NP (NP (ADJP (NP (JJ nervous) (NN system)) (JJ specific)) (NN expression)) (PP (IN of) (NP (NN EGFP) (HYPH /) (NN rtTA)))))) (. .))) )
( (CAPTION (NP (LST (-LRB- -LRB-) (LS H) (CC and) (LS I) (-RRB- -RRB-)) (NP (NN E12.5) (ADJP (JJ triple) (JJ transgenic)) (NNS embryos)) (SBAR (WHADVP-2 (WRB when)) (S (NP-SBJ-1 (DT the) (NN mother)) (VP (VBD was) (UCP-PRD (CC either) (ADJP (JJ non-treated) (PRN (-LRB- -LRB-) (NP (NN H)) (-RRB- -RRB-))) (CC or) (VP (VBN treated) (NP-1 (-NONE- *)) (PRN (-LRB- -LRB-) (NP (NN I)) (-RRB- -RRB-)) (PP-MNR (IN with) (NP (NN doxycycline))) (PP-TMP (IN during) (NP (DT the) (NN pregnancy))))) (ADVP-TMP-2 (-NONE- *T*))))) (. .))) )
( (CAPTION (S (NP-SBJ (DT The) (ADJP (NP (NN VEGF) (HYPH -) (NN A) (HYPH -) (CD 164)) (VBN induced)) (NN embryo) (PRN (-LRB- -LRB-) (NP (NN I)) (-RRB- -RRB-))) (VP (VBZ shows) (NP (NNS hemorrhages)) (PP-LOC (IN in) (NP (DT the) (VBG developing) (JJ nervous) (NN system))) (PRN (-LRB- -LRB-) (NP (NNS arrows)) (-RRB- -RRB-))) (. .))) )
( (CAPTION (S (LST (-LRB- -LRB-) (LS J) (-RRB- -RRB-)) (NP-SBJ (NP (NN Immunostaining)) (PP (IN for) (NP (NN EGFP)))) (VP (VBZ shows) (NP (NP (DT the) (NN podocyte) (NN specificity)) (PP (IN of) (NP (NML (NN Podocin) (HYPH -) (NN Cre)) (NN excision))))) (. .))) )
( (HEADING (NP (NN Figure) (CD 4))) )
( (S (NP-SBJ-1 (NP (NN Liver) (ADJP (NN peliosis) (HYPH -) (JJ like)) (NN phenotype)) (CC and) (NP (NN thymus) (NN degeneration))) (VP (VBP are) (VP (VBN associated) (NP-1 (-NONE- *)) (PP (IN with) (NP (DT the) (ADJP (NN doxycycline) (HYPH -) (VBN induced)) (JJ overall) (NML (NN VEGF) (HYPH -) (NN A) (HYPH -) (CD 164)) (NN expression))) (PP-LOC (IN in) (NP (JJ adult) (NML (NML (NML (NN pCAGGS) (HYPH -) (NN CreTg)) (HYPH /) (NML (SYM +))) (, ,) (NML (NML (NN ROSA26) (HYPH -) (NN rtTA) (HYPH -) (NN IRES) (HYPH -) (NN EGFPTg)) (HYPH /) (NML (SYM +))) (, ,) (NML (NML (NML (NN tet) (HYPH -) (NN O)) (HYPH -) (NN VEGF) (HYPH -) (NN A) (HYPH -) (NN 164Tg)) (HYPH /) (NML (SYM +)))) (NNS mice))))) (. .)) )
( (HEADING (NP (NP (NML (NN H) (CC &) (NN E)) (JJ histological) (NN analysis)) (PP (IN of) (NP (NP (NNS livers)) (PP (IN of) (NP (NP (ADJP (JJ triple) (JJ transgenic)) (JJ adult) (NNS mice)) (PP (IN of) (NP (NP (LST (-LRB- -LRB-) (LS A) (SYM –) (LS C) (-RRB- -RRB-)) (: :) (NN VEGF) (HYPH -) (NN A) (HYPH -) (CD 164) (JJ non-induced) (PRN (-LRB- -LRB-) (NP (NN −DOX)) (-RRB- -RRB-))) (CC and) (NP (LST (-LRB- -LRB-) (LS D) (SYM –) (LS F) (-RRB- -RRB-)) (: :) (NP (NN VEGF) (HYPH -) (NN A) (HYPH -) (CD 164)) (VP (VBN induced) (NP (-NONE- *)) (PRN (-LRB- -LRB-) (NP (NN +DOX)) (-RRB- -RRB-)) (PP-MNR (IN by) (NP (NN doxycycline) (NN treatment))))))))))) (. .))) )
( (S (PP (IN Without) (NP (NN doxycyclin) (NN treatment))) (, ,) (NP-SBJ (NNS livers)) (VP (VBP have) (NP (NP (DT a) (JJ normal) (JJ hepatic) (NN architecture)) (PP (IN with) (NP (NP (ADJP (RB well) (HYPH -) (VBN defined)) (NN vasculature)) (CC and) (NP (JJ normal) (NML (NML (NML (JJ hepatic) (NNS venules)) (-LRB- -LRB-) (NML (NN V)) (-RRB- -RRB-)) (CC and) (NML (NML (JJ hepatic) (NNS sinusoids)) (-LRB- -LRB-) (NML (NN HS)))))))) (-RRB- -RRB-) (PRN (-LRB- -LRB-) (NP (NN C)) (-RRB- -RRB-))) (. .)) )
( (S (NP-SBJ (DT The) (ADJP (NN doxycycline) (HYPH -) (VBN treated)) (NN mutant) (NNS livers)) (VP (VBP show) (NP (NP (JJ major) (NNS disruptions)) (PP (IN of) (NP (JJ normal) (JJ hepatic) (NN architecture))) (PP (IN with) (NP (NP (NP (DT a) (JJ severe) (NN dilation)) (PP (IN of) (NP (NP (JJ hepatic) (NNS sinusoids)) (-LRB- -LRB-) (NP (NN HS)) (-RRB- -RRB-)) (PRN (-LRB- -LRB-) (NP (NN F)) (-RRB- -RRB-)))) (CC and) (NP (NP (NN evidence)) (PP (IN of) (NP (NN blood) (NML (NN engorgement) (CC and) (NN pooling)))) (PRN (-LRB- [) (NP (NP (NNS arrows)) (PP (IN in) (-LRB- -LRB-) (NP (NN E)))) (-RRB- -RRB-) (-RRB- ]))))))) (. .)) )
( (S (NP-SBJ (NP (NN Arrow)) (PP (IN in) (-LRB- -LRB-) (NP (NN F)) (-RRB- -RRB-))) (VP (VBZ shows) (NP (NP (NN evidence)) (PP (IN of) (NP (JJ sinusoidal) (JJ endothelial) (NML (NN sloughing) (CC and) (NN detachment)))))) (. .)) )
( (CAPTION (NP (LST (-LRB- -LRB-) (LS G) (SYM –) (LS I) (-RRB- -RRB-)) (: :) (NP (NML (NN H) (CC &) (NN E)) (JJ histological) (NN analysis)) (PP (IN of) (NP (NP (NP (NML (NN VEGF) (HYPH -) (NN A) (HYPH -) (CD 164)) (JJ non-induced) (NML-1 (-NONE- *RNR*)) (PRN (-LRB- -LRB-) (NP (NN −DOX)) (-RRB- -RRB-))) (CC and) (NP (LST (-LRB- -LRB-) (LS J) (SYM –) (LS L) (-RRB- -RRB-)) (: :) (ADJP (NP (NN VEGF) (HYPH -) (NN A) (HYPH -) (CD 164)) (VBN induced)) (NML-1 (-NONE- *RNR*)) (PRN (-LRB- -LRB-) (NP (NN +DOX)) (-RRB- -RRB-))) (NML-1 (NN thymus))) (PP (IN of) (NP (ADJP (JJ triple) (JJ transgenic)) (JJ adult) (NNS mice))))) (. .))) )
( (S (PP (IN Without) (NP (NN doxycycline) (NN treatment))) (NP-SBJ (DT the) (NN thymus)) (VP (VBZ shows) (NP (NP (JJ normal) (JJ thymic) (NN architecture)) (PP (IN with) (NP (NP (NP (DT a) (ADJP (RB well) (HYPH -) (VBN defined)) (NN cortex) (NN layer) (PRN (-LRB- -LRB-) (NP (NN cx)) (-RRB- -RRB-))) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBZ is) (VP (VBN packed) (NP-1 (-NONE- *)) (PP-MNR (IN with) (NP (JJ basophilic) (NNS lymphocytes)))))))) (CC and) (NP (NP (DT a) (JJ normal) (JJ medullary) (NN layer) (PRN (-LRB- -LRB-) (NP (NN m)) (-RRB- -RRB-))) (SBAR (WHNP-2 (WDT that)) (S (NP-SBJ-2 (-NONE- *T*)) (VP (VBZ contains) (NP (NP (JJR fewer) (NNS lymphocytes)) (CC but) (NP (DT an) (JJ extensive) (JJ epithelial) (NN framework))))))))))) (. .)) )
( (S (NP-SBJ (ADJP (NN Doxycycline) (HYPH -) (VBN treated)) (NN mutant) (NN thymus)) (VP (VBZ shows) (NP (JJ massive) (NN degeneration)) (PP (IN with) (S-NOM (NP-SBJ (DT all) (CD three) (JJ thymic) (NNS lobes)) (VP (VBG fitting) (PP (IN into) (NP (DT a) (JJ single) (JJ optical) (NN field))) (PRN (-LRB- -LRB-) (NP (NN J)) (-RRB- -RRB-))))) (PP (VBN compared) (PP (IN with) (S-NOM (NP-SBJ (CD one) (JJ thymic) (NN lobe)) (VP (VBG fitting) (NP (-NONE- *)) (PP (IN into) (NP (DT the) (JJ optic) (NN field))) (PP (IN at) (NP (DT the) (JJ same) (NN magnification))) (PRN (-LRB- -LRB-) (NP (NN G)) (-RRB- -RRB-)) (PP (IN from) (NP (NN control) (NNS mice)))))))) (. .)) )
( (S (PP (IN In) (NP (NN addition))) (, ,) (NP-SBJ (DT the) (NN mutant) (NN thymus)) (VP (VBZ lacks) (NP (DT a) (ADJP (RB well) (HYPH -) (VBN defined)) (JJ cortical) (NN layer)) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (VBG owing) (PP (IN to) (NP (NP (DT a) (ADJP (RB dramatically) (VBN decreased)) (NN number)) (PP (IN of) (NP (NP (JJ basophilic) (NNS thymocytes)) (VP (VBN seen) (NP (-NONE- *)) (PP (IN at) (NP (JJR higher) (NNS magnifications)))))))) (PRN (-LRB- -LRB-) (NP (NP (NN L)) (-RRB- -RRB-) (PP (VBN compared) (PP (IN with) (-LRB- -LRB-) (NP (NN I))))) (-RRB- -RRB-))))) (. .)) )
( (CAPTION (NP (NP (LST (-LRB- -LRB-) (LS A) (, ,) (LS D) (, ,) (LS G) (CC and) (LS J) (-RRB- -RRB-)) (, ,) (QP (CD 50) (SYM ×)) (NN magnification)) (: ;) (NP (LST (-LRB- -LRB-) (LS B) (CC and) (LS E) (-RRB- -RRB-)) (, ,) (QP (CD 125) (SYM ×)) (NN magnification)) (: ;) (NP (LST (-LRB- -LRB-) (LS H) (CC and) (LS K) (-RRB- -RRB-)) (, ,) (QP (NN 250) (SYM ×)) (NN magnification)) (: ;) (CC and) (NP (LST (-LRB- -LRB-) (LS C) (, ,) (LS F) (, ,) (LS I) (CC and) (LS L) (-RRB- -RRB-)) (, ,) (QP (CD 500) (SYM ×)) (NN magnification)) (. .))) )
( (HEADING (NP (NN Table) (CD 1))) )
( (HEADING (NP (NP (NN Summary)) (PP (IN of) (NP (NP (NML (NN doxycycline) (NN induction)) (NNS experiments)) (PP-TMP (PP (IN during) (NP (NN development))) (CC and) (PP (IN in) (NP (JJ adult) (NNS mice)))))))) )
